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ABSTRACT 
The nicotinic cholinergic receptor protein of the fish electric organ, Torpedo fuscomaculata, has been isolated, 
purified and shown to represent a true model for the nAChR from other species and higher vertebrates. It is 
an integral membrane protein composed of four different subunits, tightly associated with other functional, but 
non-specific proteins. 
Purification of the nicotinic cholinergic receptor by chromatofocusing demonstrates an improved method over 
that of affinity and ion-exchange chromatography. Gel chromatography and SDS-polyacrylamide gel 
electrophoresis show evidence of four subunits; a(40-44 kDa), 6(53 kDa ),'Y(63 kDa) and 6(66 kDa) despite 
some degradation of receptor molecules by intracellular proteases. 
Spectrophotometric and fluorimetric studies of receptor-ligand interactions, show the functional and chemical 
integrity of the receptor to remain intact after solubilisation. The effect of cholinergic ligands on purified 
receptor preparations indicate quenching of the intrinsic fluorescence of the receptor. Agonists, like 
acetylcholine, bind and cause local conformational transitions, changing the active region from a hydrophobic 
to a hydrophilic environment. This phenomenon is illustrated by the 10-fold increase in fluorescence when the 
receptor is in a desensitised state. Antagonists, such as d-Tubocurarine, block this conformational transition. 
In vitro rectus abdominis muscle preparations . show the nitrosamines, dimethylnitrosamine and 
diphenylnitrosamine, to be true agonists of the nAChR. However their low affinity and specificity for the 
receptor precludes them as photoaffmity labelling agents. Photoactivation of dimethylnitrosamine occurs when 
associated with an acidic hydrogen at the active site of the receptor, suggesting energy-transfer labelling to be 
more facile than photoaffmity labelling. The membrane-bound receptor, in the presence of these nitrosamines, 
undergoes conformational transitions regulating the opening and closing of the ion-channel. Desensitisation 
and receptor activation are shown to involve one and the same molecular transition. 
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CHAPTER 1 
LITERATURE REVIEW 
2 
1.1 INTRODUCTION 
In 1906, Langley concluded his experiments on the effects of nicotine on muscle contraction in the fowl by 
postulating that a "receptive substance ... combines with nicotine and curari and is not identical with the 
substance which contracts". Sixty-five years later, the nicotinic receptor for acetylcholine was isolated as the 
first in an ever-increasing list of receptors for neurotransmitters {1). The wealth of biochemical information 
accumulated over the past fifteen years makes the nAChR the best known neurotransmitter receptor and also 
the most thoroughly investigated membrane protein (2, 3). 
Nicotinic cholinergic receptors (nAChR) mediate chemical communication at synapses in many parts of the 
nervous system of vertebrates, including neuromuscular junctions; autonomic ~anglia and certain sites of the 
brain (2). The receptor recognjses and binds specifically the neurotransmitter acetylcholine, released from 
nerve endings in the presynaptic membrane and converts the chemical signal, acetylcholine, into an electrical 
effect by allowing an influx of cations through the ion-channel. This is also known as depolarisation of the post-
synaptic membrane.(3). 
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Figure 1.1 Events at a cholinergic synapse: Acetylcholine shown acting 
post-synaptically on a nicotinic receptor controlling a cation 
channel (4). 
CAT Choline acetyltransferase 
AcCoA Acetyl CoA 
ACh Acetylcholine 
AChE Acetylcholinesterase 
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1.2 ISOLATION, PURIFICATION AND ASSAY OF THE NICOTINIC CHOLINERGIC 
RECEPTOR PROTEIN 
1.2.1 Isolation 
Marine elasmobranchs such as the Torpedo ray and the electric eel, Electrophorus electricus, provide rich 
sources of the nicotinic cholinergic receptor protein for studying structural and functional aspects of receptor 
proteins (2). 
The electric tissue of the ray is derived from skeletal muscle in which the original contractile properties have 
been lost and the capacity to generate electric potentials bas been greatly developed (5, 6). 
Figure 1.2 Ventral view of a Torpedo ray. 
The bilateral kidney-shaped honeycomb-like structure 
is the electric organ (6). 
5 
The electric organ is advantageous for the isolation and purification of the nAChR because it represents a 
homogeneous high density population of synapses, all of which are identical and exclusively of the nicotinic 
cholinergic type (1, 5). 
Electric rays can be stored frozen or alternatively, excised electric organs can be stored under liquid nitrogen at 
-7ooc. Continual freezing and thawing of the tissue releases intracellular proteases which are able to attack the 
receptor protein and render it structurally altered (7). 
Electric organ is trimmed free of adherent muscle, connective and adipose tissue and homogenised in a 
blender. The sensitivity of nAChR to proteolytic attack is well documented (8-11), therefore homogenisation of 
the receptor requires the presence of a "cocktail" of protease inhibitors in a buffered system. 
Crude homogenate is centrifuged at low speed, removing a pellet of membranous material comprising receptor 
protein. Solubilisation of this membrane protein requires the presence of non-denaturing detergents such as 
Triton X-100, Tween-20 or 80, deoxycholate or chelate (U). The concentration and type of detergent, has 
however, allowed for disparity as regards the functional integrity of the receptor protein. It is suggested that 
regulatory properties of the receptor are lost upon solubilisation with Triton X-100 and that the affinity for 
many agonists becomes altered (13). 
Recently it has been shown that the release of free fatty acids from the membrane destroys the functional 
integrity of the receptor (14). It has been suggested (15), that this form represents a desensitised receptor with 
a higher affinity for many ligands of the cholinergic system. 
It is firstly apparent that a critical ratio of detergent to lipid be maintained if active protein is to be released 
from the membranes (16) and secondly, milder detergents be used, aimed at minimising alteration of structural 
features (17). 
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1.2.2 Purification 
Attempts at isolating and purifying the receptor protein by conventional methods such as gel ftltration, 
electrophoresis, electrofocusing or density gradient centrifugation met with little success due to either low 
yields and/or denaturation of receptor protein (6, 18). Several years later however, conventional methods 
regained popularity since nAChR-rich membranes became available in significant quantities from Torpedo 
electric organ. Centrifugation at low and high speed is sufficient to give the nAChR in a relatively pure form 
and in milligram quantities from a crude-detergent extract (13). 
1.2.2.1 Gel filtration 
Purification of biological macromolecules on the basis of size is reliable and simple in comparison to most other 
techniques, however, the resolving power is limited by chromatographic factors and cannot really yield fractions 
of discrete molecular size. 
Acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of acetylcholine at the post-synaptic 
membrane, has a similar molecular weight (250 kDa) to its receptor protein (19), and hence the use of 
Sephadex G-200 or Sepharose 6B gels have not proved entirely successful (12, 19, 20). A 3.2-fold purification, 
using Sepharose 6B, for nAChR has been reported, but contamination of this purified material with non-
specific proteins is suspected (20). 
1.2.2.2 Ion-Exchange Chromatography 
The resolving power of this technique is superior to gel ftltration in that separation is based on differences in 
charge rather than on the size of macromolecules. It is however not sufficiently characteristic, allowing certain 
proteins to elute under similar conditions (21). 
DEAE-Sephadex A-25, an anion-exchange ge~ bas frequently been employed in conjunction with affinity 
chromatography for purifying the nAChR. Desorption of receptor occurs in the presence of 0.5 M salt (5, 22). 
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1.2.23 Density Gradient Centrifugation 
Post-synaptic membranes highly enriched in nicotinic receptors show an unusually high protein to lipid·ratio 
(2:1) (the electric tissue originally been derived from skeletal muscle). These membranes can therefore be 
isolated from homogenates of electric tissue by equilibrium ultracentrifugation on sucrose density gradients 
(23). Membranes are separated into two fractions; those sedimenting through the gradient and those retained 
by the gradient. The membranes retained, have been shown to consist of highly purified nicotinic post-synaptic 
membranes (23). These membranes do, however, consist of non-receptor proteins as evidenced upon 
subsequent characterisation. Further purification by alkaline treatment and discontinuous or continuous 
sucrose gradient centrifugation appeared necessary to obtain a more homogeneous population of receptor 
molecules (23-26). 
1.2.2.4 Isoelectric Focusing and Chromatofocusing 
Purification and fractionation of proteins from biological fluids is facilitated by their different isoelectric points. 
The possibility of producing a pH gradient using an ion-exchange column has provided techniques for 
separation with resolution and recovery comparable to those of electrophoretic systems. With ampholyte 
displacement chromatography, a pH gradient is produced by mixing buffers of different pH or by employing 
the buffering action of an ion-exchanger and a running buffer initially adjusted to one pH through a column, 
adjusted to another pH (27). This column chromatographic method is also known as chromatofocusing. 
Chromatofocusing was first mentioned in 1978, when the popularity of affinity chromatography precluded its 
use for purifying the receptor. A 63-fold purification of the receptor bas been achieved using isoelectric 
focusing (28). This is the highest fold purification reported for the classical biochemical techniques discussed 
so far. 
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1.2.2.5 Affinity Chromatography 
Since 1972, afftnity chromatography has been the method of choice for purifying the receptor. This technique 
enables the purification of biomacromolecules on the basis of their biological function or individual chemical 
structure (29). The method is based on the ability of proteins to reversibly bind ligands with high afftnity that 
are covalently attached to a gel matrix (18). The higher the afftnity of the binding the more speciftc, and hence 
the easier the removal of unwanted material on elution. 
1.2.2.5.1 Neurotoxins as Affinity Ligands 
The snake a-neurotoxins possess the extraordinary properties of binding with very high affinity and specificity 
to the nicotinic cholinergic receptor. These neurotoxins are therefore ideal ligands for purifying the receptor in 
an affinity chromatographic system (5). Two neurotoxins of importance are n-bungarotoxin from Bunganls 
multicinctus and a -cobratoxin from Naja Naja siamensis. The former normally being used to detect the 
receptor because of its irreversible nature of binding (2), while the latter displays a lower affinity, but similar 
specificity for the receptor and is therefore used in purifying the protein according to its reversible binding. It 
has been shown firstly, that the toxins have a multipoint attachment to the receptor involving several locally 
separate structural elements of the toxin and secondly, that they interact only with the receptor and not with the 
enzyme, acetylcholinesterase as do other cholinergic ligands (30). 
Neurotoxins, covalently linked to a solid support such as Sepharose 4B gel, following activation with cyanogen 
bromide, allows only 5-10% of the immobilised toxin the ability to bind nAChR (5, 9, 12, 22, 28). 
Approximately 1 mg/cm3 of toxin is incubated with the affinity resin prior to adding solubilised receptor 
material (8). Typical recoveries are : 4-6 mg from an initial 200 g of electric organ (8) and 10 mg from 100 g 
(31). Disparity amongst the literature makes strict comparisons extremely difficult, however the many excellent 
reviews that have appeared, show without a doubt, the popularity of affmity chromatography (28, 32-35). 
9 
Fold purifications vary from 13.9-fold (20) to 60-fold (22). Obvious disadvantages of this technique are the 
time taken to perform affmity chromatography (22, 36); the difficulty in reversing or dissociating receptor from 
bound toxin (22) and obtaining material with modified binding properties once removed from the bound toxin 
(25). It is evident from electrophoretic criteria that the material ordinarily eluted from the column is not pure 
(12) and is of low yield (22). Apart from Sepharose-linked neurotoxins many quaternary ammonium 
compounds have been investigated as possible affmity ligands. 
1.22.5.2 Other Affinity ligands 
Many ligands of the cholinergic system show a characteristic quaternary nitrogen atom responsible for the high 
affinity and specificity for the receptor (37). Among these compounds, quaternary ammonium ligands have 
been studied and found to interact specifically with the receptor. Eldefrawi and E ldefrawi (18) have used 
phenyltrimethyl ammonium iodide as an affinity ligand but only achieved a 10-fold purification with very low 
recovery. Crude receptor protein has been adsorbed onto an affinity column containing an analogue of flaxedil, 
linked to Sepharose 2B, then eluted with a solution of flaxedil (gallamine trimethiodide) (see below).This 
method gave a 210-fold purification with a 30% yield representing 6-8 mg of purified material (24). Trimethyl 
(p-aminophenyl) - ammonium chloride has been covalently attached to Sepharose 4B through two lengths of 
the arm -NH(CH2)3NH-(CH2)3-NHCO(CHz)CO -; this gave a 3 800-fold purification from mammalian 
muscle, with biospecific elution using flaxedil (36). These same authors performed a similar purification on 
mammalian muscle (38) but reported low yields despite a 2 400-fold purification. 
Gallamine 
Electroplax from Narcine ray has been purified 13.9-fold with a 35% recovery, by covalently linking N-(£-
aminohexanoyl) 3- aminophenyl trimethyl ammonium bromide hydrobromide to agarose gel (20). 
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It iS evident that the low yields obtained using these ligands, have favoured the more popular use of 
a-neurotoxins as affinity ligands. 
1.2.3 Assay 
Several satisfactory methods have been developed for the detection of receptor sites. Most of these assays are 
based upon the formation of a radiolabelled toxin-receptor complex {39). The most versatile method, involves 
the separation of free toxin and toxin-receptor complexes by gel flltration on small columns of Sephadex G-100 
or G-50 (5, 6). Another method involves the precipitation of toxin-receptor complexes in 30% ammonium 
sulphate and collection of precipitate on Millipore ftlters (5). The former method suffers a disadvantage when 
extremely small amounts of nAChR are assayed while the latter has the problem of coprecipitation of the free 
toxin along with the complexes. Assaying in the absence of detergents is necessary since receptors tend to 
aggregate in the absence of detergents (2, 5, 18, 24), allowing the complexes to be retained on the fllters. 
A method making use of the receptors intrinsic fluorescence has been used where toxins, binding to the 
receptor, cause quenching of the proteins fluorescence ( 40). The fluorescence intensity reaches a plateau, 
indicating saturation of the binding sites and hence direct determination of the concentration of active receptor 
sites {40). This method proves reliable and reproducible without many of the difficulties mentioned above. 
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1.3 PROPERTIES OF THE NICOTINIC CHOLINERGIC RECEPTOR 
1.3.1 Molecular Structure 
The purified receptor is a pentameric glycoprotein composed of five polypeptide chains of four different but 
homologous subunits. The resulting quaternary structurea1~,,..6, represents a functional monomer unit (3, 14). 
The molecular weight of the monomer receptor is between 250 kDa and 270 kDa (2, 3, 11, 41). Values vary 
considerably, from as low as 230 kDa to as high as 430 kDa (1, 6, 13, 36, 42), depending on the amount of 
detergent and glycosylation present. The receptor can exist as monomers and/or dimers; dimers consisting of 
two identical monomers, covalently crosslinked by an intermolecular disulphide bridge (1, 3, 13, 15)(Table 1.1). 
1.3.2 Criteria of Purity 
Several criteria are employed to determine the homogeneity of a purified preparation. These include specific 
activity, molecular weight, subunit weight, and the isoelectric point. 
1.3.2.1 Specific Activity 
The a-neurotoxins are used for assaying receptor sites as mentioned in 1.23. Values vary, depending on the 
source of material and/or method employed. Specific Activities are: 3.5J.I.Moles/g of protein (36), 2-6J.I. Moles/g 
(38) and 7.5 pMoles/g (which is a theoretical figure based on a molecular weight of 267 kDa) (2) and 121l 
Moles/g of protein have been reported (6). 
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TABLE 1.1 MOLECULAR PROPERTIES OF nAChR FROM ELECTRIC TISSUE (5) 
SPECIES 
Torpedo nobiliana 
Torpedo marmorata 
Torpedo califomica 
Electrophorus 
electricus 
MOLECULAR WEIGHT 
BY GEL FILTRATION 
250 000 (Triton) 
88 000 (Triton) 
180000 
150 000 (Triton) 
300 000 (Triton) 
450 000 (Triton) 
300 000 (Lubrol) 
500 000 (Triton) 
330 000 (Triton) 
550 000 (deoxycholate) 
500 000 - 600 000 (Triton) 
360 000 (Triton) 
From table 1.1 it can be seen that an accurate assessment of the molecular weight of the receptor is 
complicated by the presence of detergent in the purified preparations, accounting for the large variations in 
molecular weight reported (6, 9, 43). 
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1.3.2.2 Molecular weight of subunits 
The o.2,~, -y, ~ pentameric structure can only be dissociated under denaturing conditions in the presence of 
sodium dodecyl sulphate (1, 3). 
For many years there has been controversy in the literature as to the subunit composition of the receptor. 
Some groups have reported four kinds of subunits, whereas others claimed that the nAChR only consists of o. 
-subunits (11, 12). The reason for the disparities is largely due to the different sources of material and because 
of the variety of electrophoretic conditions chosen (2). Preparations, where it has been feasible to minimise 
proteolysis, show four major polypeptides with the following molecular sizes: o.(40-45 kDa); 8(49-53 kDa);-y 
(53-56 kDa) and 6(57-68 kDa) (2). Others have reported specific values of 40 kDa, 50 kDa, 60 kDa and 65 kDa 
(42, 44) or 39 kDa, 48 kDa, 58 kDa and 64 kDa (1) for the o., ~.-rand 6 subunits respectively. The Laemmli 
method (45) or the Weber and Osborn (46) method have been used in determining the above values. 
Incomplete inhibition of proteolysis during the purification can cause proteolytic nicking of the B, -y and 6-
subunits so that only the ctsubunit, which appears to be more resistant, is apparent on gel electrophoresis (11). 
A polypeptide of approximately 130 kDa has also been identified in several studies (11, 15,' 43, 47). This has 
been shown to be the result of two subunits linked through a disulphide bond, hence Torpedo nAChR exists as 
a dimer in its native membrane state (11). 
Table 1.2 gives the subunit molecular weight and specific activities of various species of purified nAChR (13). 
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TABLE 1.2 SPECIFIC ACTMTY AND CHAIN COMPOSITION OF nAChR·RICH MEMBRANES AND 
DETERGENT PURIFIED nACbR (13) 
ORGANISM POLYPEPTIDE CHAIN SPECIFIC 
(MOI-wt.X to3) ACilVITY 
pM/g) 
Cl a 'Y 6 
ACbR-rich 
membranes 
T. caJifomica 41 51 60 64 (105) 4 
40 49 60 69 2.9-4.6 
T. mannorata 40 43 (50) (66) (100) 4 
Purified 
~ 
T. califomica 26;35 42 7 
40 49 60 67 
39 48 58 64 4 
40 48 62 66 
41 51 60 64 8.8 
40 48 59 67 140 10.12 
T. nobiliana 33.5; 35.5;38.5 43.5 u.2 
T. oct/lata 40 50 61 81 10 
T. mannoraJa 42 9.5 
41.5 6 
46 
45 50 2.3 
42 50 70 
'51 49 74 93; 148 (7) 
40 (50) (66) 9 
Electrophorus 
electricus 
160 11 
44 50 4.5 
43 6 
42 7.5 
41 2.4 
42 49 6 
48 54 60 110 3.6 
43 48 54 7.5 
From the table it is evident that similarity occurs amongst different species but not between the various subunit 
molecular weights reported by the different laboratories. 
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Treatment of purified nAChR with trypsin or chymotrypsin illustrates the effect of proteolytic nicking. All 
subunits are smaller than 4{) kDa after treatment and in cases where severe treatment is performed, the largest 
components are in the order of 8 kDa (6). 
It has been suggested that the 50 kDa chain is derived from the 66 kDa chain by proteolysis (7). Work by Ong 
and Brady (22) suggested four subunits of molecular weights 43.5 kDa, 38.5 kDa, 35.5 kDa and 33.5 kDa. 
Subunits of 28 kDa, 38 kDa and 45 kDa have also been reported (20). Failure to inhibit protease attack can 
therefore result in erroneous estimations of subunit molecular weight. 
More recently (44, 48) it has been shown that a suspected cytoskeletal element of molecular weight 43 kDa is 
simultaneously purified with the receptor. This 43 K protein is thought to participate in anchoring the receptor 
at the post-synaptic site by linking the "receptor" to the cytoskeleton (48). It is therefore not a general 
membrane-associated element, but functions through its occurrence, with the acetylcholine receptor. 
1.3.2.3 Chemical Properties 
The nAChR displays an overall high acidic nature which is reflected in its low isoelectric point. Isoelectric 
focusing with broad pH gradients, indicate in most cases, homogeneous purified preparations, whereas narrow 
pH gradients reflect micro-heterogeneity (2, 13). Reported pi values are 5.0 (2); 4.8 (18); 5.3 (25); 4.9 (28), 
and 5.3 (38). 
Narrow pH gradients give values of 4.5-4.8 (6); 4.8-5.0 (9) and 4.8 - 5.2 (13), indicating broad peaks and hence 
micro-heterogeneous preparations. 
Accurate pi values are therefore clearly an indication of purity which, together with molecular weight 
determinations on PAGE/SDS-PAGE and specific activity assays, give an indication of the homogeneity of a 
purified receptor preparation. 
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1.4 PHOTOAFFINI'IY LABELLING AND PHOTOCHEMISTRY 
OF POTENTIAL NICOTINIC CHOLINERGIC LIGANDS 
1.4.1 Principles and Criteria 
A profitable approach to the analysis of receptor structure involves the use of specific, irreversibly acting 
molecules which will covalently label the receptor site and which, with appropriate labelling techniques, permit 
the isolation of receptor material ( 49). 
Current techniques include energy-transfer induced labelling and photoaffmity labelling. The former method 
takes advantage of the fact that most proteins emit light when excited at the upper region of their absorption 
spectrum. A photosensitive ligand can therefore be decomposed to a reactive species when the ligand is in 
close proximity to the active site of a receptor. Certain prerequisites have to be met however: the photolabile 
ligand should be stable at the excitation wavelength (about 290 nm); it should be an efficient fluorescence 
quencher, and finally, should be photosensitive at the emission wavelength (about 340 nm) (50). There are few 
ligands however that meet all of the above criteria, and hence behave appropriately in energy-transfer induced 
reactions leading to covalently modified receptor active centres. 
Photoaffmity labelling requires that the ligands have an inherent affinity for a binding site and possess 
biological activity. The ligands must also contain a photosensitive functional group which, when photoactivated, 
is capable of forming a covalent bond at or near the binding site of a receptor (51). For high affmity ligand-
receptor interactions to take place precise knowledge of the geometry of the binding site must be known ( 49). 
The photoaffinity label should therefore have an affinity for the active site, bind reversibly and only become 
covalently attached once photoactivated by light. The light source used for photolysis must also be suited to the 
absorption spectrum of the photoaffmity label (51). 
The criteria for active site labelling are based on the relationship between a physiological response and the 
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specificity of the interaction. The photodecomposed ligand tends to react immediately with its surroundings, 
implying non-specificity due to high reactivity (52). 
Nearly every known neurotransmitter receptor has been photolabelled to date, this facilitating the biochemical 
and biophysical characterisation and isolation of many cellular molecules (51). The fact that photoaffmity 
labelling is directly applicable to intact cells or isolated organ preparations (51) lends credence to the 
pharmacological understanding of ligand-receptor interactions. A major drawback of photoaffinity labelling, 
which does not apply to energy-transfer labelling is the damaging effects of U.V. light on the preparation. It is 
imperative then, that a desired level of covalent insertion be achieved with, simultaneously a reduced level of 
toxicity (51). 
A simple scheme for photoaffmity labelling appears as follows (52). 
L + R L R 
lost 
~ 
3 
where (1) represents a slow rate to equilibrium of ligand and 
receptor (2) photodecomposition by light and (3) instantaneous 
covalent linkage between reactive species and receptor. 
1.4.2 Photoaffinlty Labelling of nAChR 
L-R 
The nicotinic cholinergic system had been well characterised prior to the application of photoaffinity or energy-
transfer labelling techniques, due to the availability of specific and reversibly-binding ligands with biological 
activity and high affinity. Since reversibly-bound ligands dissociate from the receptor during chromatographic 
or electrophoretic procedures, it became imperative to be able to covalently label the active site of the receptor 
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and through this, allow further progress to be made towards the ultimate characterisation of the nAChR. 
Early attempts at labelling the receptor resulted in inactivation of the receptor protein and non-specific 
interactions due to saturation of binding sites (53). These same authors did however show that ammonium aryl 
azides are potential photoaffmity ligands, decomposing to reactive-nitrenes upon photolysis. The reactive 
nitrenes irreversibly inactivated the enzyme acetylcholinesterase and the receptor molecule of the intact frog 
sartorius muscle (53). 
The goal of receptor isolation, an ambitious one in biochemical pharmacology, has made good use of 
photoaffinity labelling. A list of potential photoaffinity labels and their applications are reviewed (51). More 
recently, attempts have been made to localise ligand binding sites and hence characterise the structural features 
of the various polypeptide subunits in the functional monomer (54). The requirement and usage of ligands of 
high affinity and specificity have resulted in specific covalent interactions, and thus incorporation in particularly 
functional active sites. It is for this reason that photoaffinity ligands have not replaced the more conventional 
use of affinity chromatography and related techniques for purifying the receptor. Photoaffinity labelling has 
been, and still is, utilised as a structural probe of the receptor complex, rather than a form of purification of the 
receptor molecule. 
The use of naturally photolabile underivatised ligands such as a-bungarotoxin, have proved to be extremely 
useful in labelling the receptor. The main advantage to be gained using natural photolabile ligands over 
photoaffinity analogues of ligands, is that the bulky photosensitive moeity is not present. Secondly, the potency 
and efficacy of the compound has not changed as can occur when a ligand is derivatised (51). Raftery et. al. 
(55) derivatised a-bungarotoxin by adding aryl azide side chains to the toxin. This allowed firstly that the 
polypeptide to which the toxin derivative binds and an adjacent polypeptide be derivatised upon photolysis or 
secondly, only the adjacent polypeptide be labelled. 
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Ligands, amongst others, that have proved useful in identifying the acetylcholine binding site are 4-(N-
maleimido)-C3H]-benzyltrimeth~ammonium iodide (l3f.[]MPTA); p-(N,N-dimethyl amino)-benzene diazonium 
fluoroborate ([3H]DDF) (see below); [3H] bromoacetylcholine and more recently [14C]chloroacetylcholine 
perchlorate. The first ligand is a sulphydryl-directed affinity reagent labelling a single a.-subunit cyanogen 
bromide fragment. The second photoaffJ.Dity ligand, DDF, offers significant advantages over MPTA in that it 
labels native nAChR without prior reduction, a modification known to produce marked changes in the 
conformation of this site. Also the photolabile diazonium moeity may interact directly with the 
tetraalkylammonium binding site providing a more detailed view of the structure of the acetylcholine binding 
site, in its native conformation (56). 
DDF 
MPTA 
The alkylating agent, chloroacetylcholine was found to be more applicable in labelling the receptor than 
bromoacetylcholine affording specific alkylation at theo.•subunit. Detection in SDS-PAGE was found to be 
considerably easier due to the use of[14c ]instead of[3H](57). In photoaffmity labelling, not enough protein is 
radiolabelled for easy detection on a polyacrylamide gel because of the low efficiency of a photolabelling 
process (52). 
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A series of halodibenzo-p-dioxins with the photolabile aryl azide functional group have also been synthesised 
and screened as potential photoaffmity labels for the nAChR. The labels were directed against rodent liver 
preparations and led to the characterisation of the receptor in mouse liver cytosol (58). 
A photosensitive 0-nitrobenzyl moeity has been attached directly to the carbamate nitrogen of the well 
characterised acetylcholine analogue, carbamylcholine. This derivatised compound showed major advantages 
over other photoactivatable acetylcholine analogues, in that the linkage of the 0-nitrobenzyl group to a 
nitrogen, suggested preparation of photoactivatable derivatives of other neurotransmitters that contain an 
amino group (59) [3H]_ Tubocurarine has also been employed as an affinity label for the agonist -binding site 
(60), but was found to be incorporated into all the nAChR subunits. 
Affinity labels have also been used in attempts to identify the location of the allosteric antagonist binding site, 
one such compound is meproadifen mustard (see below). This ligand alkylates several polypeptides in addition 
to nAChR subunits with specific alkylation of the a and B subunits (60, 61). 
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Non-competitive antagonists (see below) also serve as useful tools for the identification of functionally 
important domains of the receptor (61). For the case of nAChR they include trimethisoquin, phencyclidine, 
perhydrohistrionicotoxin and chloropromazine. Chloropromazine photolabels specifically the 6 and 6 chains of 
the receptor in the presence of the agonist carbamylcholine, whilst reduced labelling occurs in the presence of 
phencyclidine (54). Earlier studies by this group showed that chloropromazine heavily labelled all four 
polypeptides (a., 8, 'Y, 6). From these studies and others (62-64) the idea that the 6 chain is involved in the 
binding of all of these non-competitive blockers is therefore conclusive. Of the ligands that gave successful 
labelling, all had a carbon ring with important substituents (62). Triphenylmethyl phosphonium, frequently 
used as a voltage sensor in membrane systems, binds reversibly to the «-subunit of the receptor but not at the 
acetylcholine binding site. This same ligand, once U.V. irradiated in the presence of the receptor, alkylates the 
« ·subunit, but, in the presence of carbamylcholine, labels preferentially the « and B -subunits. This can be 
in.terpreted as an indication of a rearrangement of the receptor's quaternary structure on binding agonists (65). 
Pt>en<:yclldlne 
Histrionitatoxin 
TPMP' 
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Aryl diazonium salts have been described as irreversible blockers of the phencyclidine binding site. In the 
presence of carbamylcholine, interaction with all four subunits of the receptor occurs. Among these diazonium 
salts, an imidazole derivative is unique in that the photoinduced irreversible blocking is only effective when the 
receptor is in a desensitised state (66). 
Recently, Middlemas and Raftery (67) included cholesterol as an affinity probe. Synthesis of[3H] cholesteryl 
diazoacetate, capable of incorporating itself into lipid bilayers, demonstrated that cholesterol interacts with all 
four subunits of the nAChR. 
The pattern of labelling is dependent on the structure of the photosensitive ligand as well as the state (open, 
closed etc.) and source of receptor (66). The popularity of an affinity ligand will be governed essentially by its 
structure and hence reactive products upon photolysis. Of all the ligands, the aryl azides have the most 
predictable photodecomposition under mild U.V. irradiation (52). Problems of efficiency, stability and 
specificity in labelling are never completely overcome but the aryl azides on decomposing to aryl nitrenes have 
proved to be the best (52). 
Energy-transfer and photoaffinity labelling of acetylcholinesterase using p(N,N-dimethylamino)- benzene 
diazonium fluoroborate (DDF) has allowed a direct comparison of these two techniques. Photolysis of the 
enzyme-DDF complex at 410 om resulted in less inactivation of the enzyme than when energy-transfer between 
the enzyme and DDF occurred at 295 om. The latter method showed an increase in the rate of enzyme 
inactivation and a bette~ stoichiometry of covalent labelling (68). At high concentrations of inhibitor however, 
non-specific labelling is increased due to the increase of the amount of uncomplexed ligand (68). 
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1.4.3 Nitrosamine Photochemistry 
Nitrosamines are amongst the most powerful carcinogenic chemicals known and are easily converted, after in 
+ 
vivo cx-hydroxylation,to alkylating species which may be the diazoalkane (R-CH=N=N), the diazonium salt (R-
+ + 
CH2-N=-N) or the carbonium ion (R-CH:z) (69, 70). 
The nitrosamines are pharmacologically interesting agents capable of highly selective enzyme inactivation (69) 
and can prove to be selectively toxic to organisms or tissues possessing the requisite activating enzyme. 
Extensive interest in the photochemical reactions of nitroso-compounds began in 1964. It was discovered that 
the N-Nitrosamines remain stable towards U.V. irradiation in neutral solution but undergo various 
photoreactions in the presence of a dilute acid (pH1-3) (50, 71). It is reasonable to suppose that the dilute acid 
promoted photolability of the nitrosamines through association with their dipolar character. Structure II 
(figure 13) possesses a 48% contribution of polar resonance form, suggesting a slight favour towards the non-
charged resonance structure I (figure 1.3) (71). 
R, ~0 R 0 '\+ / 
N -N 7 N=N 
I / 
R R 
I ][ 
Figure 1.3 Resonance forms of Nitrosamine compounds. 
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Photolysis of III (figure 1.4) results in the formation of nitrosyl and a.minium radicals by dissociation of the N-N 
bond. 
[-
R 0 
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N :.:.: N 
/ 
R 
:n:r 
+ 
H hV 
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/ 
NO 
R 
+ 
H 
Figure 1.4 Photochemistry of N-Nitrosamines. 
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Ultraviolet spectroscopy studies of nitrosamines in aqueous sulphuric acid have demonstrated that at low 
concentrations of acid (pH 1-3) association through hydrogen-bonding is the primary mode of interaction (III-
IV) (figure 1.4) (71, 72). At higher concentrations of acid, nitrosamines are protonated on the nitroso oxygen 
(VI). It is the former (IV) but not the latter (VI) that is photolabile (71). 
Dimethyl-N-Nitrosamine (DMN) shows absorption maxima at 228 nm and 332 nm in aqueous solution in the 
absence of acid. An increase in the acidity results in a decrease of the intensity of these absorption maxima, 
with complete disappearance in concentrated acid (72). It is therefore favourable to mimic a medium in which 
the nitrosamines are most photosensitive. Mediums of low dielectric constant; non-polar solvents such as 
heptane or chloroform in the presence of trifluoroacetic acid tend to enhance the photoreactivity of the 
nitrosamines (50, 73). DMN in non-polar solvents exhibits absorption maxima at 220 nm and 360 nm. Shifts in 
the absorption maxima are best explained by hydrogen-bonding in a solute-solvent interaction. The amount of 
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shift appears to be of the order of the hydrogen-bonding ability (not acidity) of the solvent (73). 
Anatoxin-a is a potent nicotinic acetylcholine receptor agonist (74). 
HN~ 
The geometry of anatoxin-a has been determined by x-ray crystallographic spectroscopy and force field 
calculations. Comparisons of this conformation with models proposed for acetylcholine receptor activation 
(75) shows good agreement and allows for further inferences concerning the stereocliscrimination by the 
receptor. Since a planar configuration is shared by both anatoxin - a and DMN (76), the nitrosamines are 
considered as potential ligands for the proteins involved in the cholinergic system and as a preamble they are 
also the simplest in structure. 
The stereocliscrimination by the nAChR suggests that in nicotine the role of the carbon skeleton is simply to 
provide proper stereochemical localisation of the functional group. Good correlation between lone pair 
directionality and ligand protein binding is essential. The nAChR donates a hydrogen bond to the agonist and 
recognises the plane defmed by the hydrogen-bonding system. The distance between the electrostatic 
interaction (i.e. quaterinised N) and a hydrogen-bonding acceptor is of paramount importance (50). An 
additional interesting feature of these molecules is that their -N2 moeity which is responsible for their affmity is 
also the photolabile function. It may therefore be possible to covalently label the residues belonging to the 
quaternary ammonium binding site. 
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It has been suggested (50) that the nitrosamines were specifically photoactivated after association with an acidic 
hydrogen at the active site (69, 71). 
Nitrosamine derivatives have been shown to irreversibly inhibit acetylcholinesterase in the presence of light 
(69); the inactivation rate being maximal at a photolysis wavelength of about 335 nm. Methyl (acetoxymethyl) 
nitrosamine (MAN) is a poor competitive inhibitor of this enzyme (Km = w-2M). AchE inactivation suggests 
that there is at least one protonated residue in the enzyme active site and that the active site must be 
hydrophobic in nature. Thirdly there are certain chemical requirements which induce photoactivation when 
complexed at the active site, based on the fact that only 24% of MAN is degraded after 20 min in an aqueous 
acidic medium (69). 
1.5 
27 
MOLEC~ INTERACTIONS BE1WEEN LIGANDS AND 
THE NICOTINIC CHOLINERGIC RECEPTOR 
1.5.1 Regulation of ionic permeability 
Receptors are coupled to many different types of cellular responses, some of which may be very rapid, i.e. 
_millisecond time scale, or very slow with a time scale of hours. In the case of neurotransmitters, these receptors 
are located in the plasma membrane and convey the signal through second messenger systems from outside the 
cell to the inside. Depending on whether the second messenger is an ion or a low-molecular weight compound 
like cAMP, will decide whether the receptor is coupled to an ion-channel (Type I) or an enzyme catalysing the 
synthesis of the second messenger (Type II). A prototype of the channel-coupled (Type I) receptor is the 
nicotinic cholinergic receptor found at the neuromuscular junction (3). Type I exhibits the fastest type of 
receptor-mediated response, when a neurotransmitter acts on the post-synaptic membrane of a muscle cell, 
transiently increasing its permeability to particular ions ( 4). The speed of this response makes it likely that the 
coupling between receptor and the ionic channel is a direct one (4). 
The effect of acetylcholine binding to the receptor on the post-synaptic membrane is to cause a large increase 
in its permeability to small cations, particularly sodium and potassium ions and, to a lesser extent, calcium ions. 
Because of the large inwardly-directed electrochemical gradient for sodium ions across the cell membrane, an 
influx of Na + ions occurs, causing depolarisation of the post-synaptic membrane. This transmitter mediated 
depolarisation is called an endplate potential (epp). In the muscle fibre the localised epp spreads to adjacent 
electrically excitable parts of the muscle fibre. If its amplitude is sufficient to reach the threshold for excitation 
an action potential is initiated, which propagates to the rest of the fibre and evokes a contraction ( 4). 
1.5.2 Molecular mechanism of nAChR action 
There are three main classes of cholinergic effector molecules: agonists, competitive antagonists and non-
competitive antagonists. The term ligand, synonomous with effector molecule is commonly used to describe 
any substance that binds a particular type of receptor. 
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1.5.2.1 Agonists 
Agonists-like the natural neurotransmitter acetylcholine-bind to nAChR and activate it (3). 
1.5.2.1.1 Structural- functional aspects 
Nicotine, a tertiary amine, exists mostly as the univalent nicotinium ion at physiological pH (figure 1.5 (i) + 
(ii)). It is this nicotinium ion that specifically activates the nicotinic receptor (77). 
Nicotine Nicotinium ion 
ii 
0 
x- CH, u 
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Figure 1.5 Structures of nAChR agonists 
Several structural features of agonists are important for recognition of the cholinergic receptor. 
(i) Cationic head: The quaterinised nitrogen atom is mainly responsible for t?e affinity for the receptor and 
agonist activity. 
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Simple tetramethylammonium ions (CH3)4N stimulate both nicotinic and muscarinic receptors, although are 
considerably less potent than acetylcholine. The importance of the positive charge suggests that the 
initial attraction between acetylcholine and the receptor is an electrostatic one. An increase in the size of the 
quaterinising groups, i.e. (replacement of methyl groups with longer alkyl chains) results in reduction of 
activity, but simultaneously an increased affinity for the receptors (77). 
(ii) The ester link: The ester link is important in that both the carbonyl and ether oxygens of acetylcholine 
are involved in the combination with the receptor, the carbonyl oxygen being relatively more important for 
nicotinic activity. This suggests that additional active sites on the receptors (positively charged areas) are 
present, interacting with the partial negative charge at the "appropriate position" in the active compound (77). 
Aromatic compounds such as phenyltrimethylammonium (figure 1.5 (iv)) are potent agonists of nicotinic 
receptors but poor muscarinic agonists. Their increased potency over acetylcholine is due to the partial 
negative charge on the electron-attracting benzene ring in place of the carbonyl oxygen of acetylcholine (77). 
(iii) The acetyl group: Choline possesses all of the pharmacological properties of acetylcholine but is 100-100 
000 times less potent. The reason being, that the hydroxyl group of choline impairs its reaction with the 
receptor. Possibly, hydrogen-bonding between the hydroxyl group and water molecules prevents its close 
approach to the receptor (77). The absence of the acetyl group in carbamylcholine (figure 1.5 (v)), which 
stimulates both nicotinic and muscarinic receptors, emphasises the importance of this group for specific 
nicotinic recognition. 
(iv) The alkylamine chain: Branching of the chain alters the activity of acetylcholine-like molecules. The 
addition of a methyl group to the 6 -carbon atom for example, results in almost complete loss of activity. 
Optimum length of the chain is five atoms ( cf acetylcholine), but is not a strict rule for nicotinic agonists. 
From all of the above structural features, it would appear that the cationic head and the carbonyl oxygen atom 
are the most important features necessary for nicotinic recognition. 
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1.5.2.1.2 Cooperative interactions and conformational changes 
In 1937, Clarke pointed out that; "not only must a ligand bind on a receptor in order that a response qe 
observed," but "must also produce an effect" (78), i.e., a specific structural change must be induced in the 
receptor. 
Methods of studying cellular responses have been by several means: mechanical, which is the simplest method 
involving muscle contractions; electrophysiological methods eg. patch-clamp techniques, and many biochemical 
binding assays. One drawback of the first two methods is that association and dissociation constants for 
agonists cannot be accurately determined because the concentration of ligand present at the receptor is 
unknown. Dose-response curves in the presence of agonists give unreliable estimates of Ka and Kd for 
receptors because the relationship between receptor occupancy and response is usually non-linear ( 4, 79). 
The study of response as a function of agonist concentration is a direct and very widely employed strategy for 
the study of receptor activation. These kind of studies have provided evidence that activation of the 
acetylcholine receptors and probability that the channel is open, is greatest when two ligand binding sites are 
occupied (1, 6, 80-82). It has been suggested that singly liganded receptors which exist at low agonist 
concentration make a small contribution (82, 83). 
Positive cooperativity has been detected, i.e. binding of one molecule to the receptor enhances the binding of 
the second molecule to the receptor (6). Evidence for this, comes from calculation of the Hill coefficient which 
was found to be between 1.6 and 2.0 indicating two binding sites interacting allosterically. Two early models 
attempting to explain similar observations are those of Monod, where the protein oscillates spontaneously 
between two conformations and those of Koshland's induced fit model where binding of a ligand to one subunit 
of the protein induces changes in the conformation of the protein which make it easier (or more difficult!) for a 
second molecule. to bind to the other subunit (6). 
The present assumption is that binding of Ach to it's receptor induces a "change in the conformation" of the 
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receptor, which in turn allows a second molecule of Ach to bind causing the channel to open and hence ions to 
flow through it. Not only does the receptor change its conformation upon binding of an agonist, but it appears 
also to change into a third conformation when in a desensitised state (6). 
Jackson (82) gained significant insight into the mechanism of receptor activation usmg the agonist, 
carbamylcholine. "The flrst ligand binds tightly, but accelerates the rate of channel opening by only a factor of 
40, and increases the channel mean open time by a factor of 5 . The second ligand binds less tightly than the 
first, but accelerates the rate of channel opening by an adclitional factor of 2 500 . Binding of the second 
ligand increases the mean open time by another factor of 5." The major effect of ligand binding is 
destabilisation of the closed state as opposed to stabilisation of the open state. Jackson deduced that the 
ligand-receptor interactions at the two binding sites are similar in strength when the channel is open, but 
substantially different when the channel is closed (3, 80-83). The clifference in binding affinities for an agonist 
is a new observation that was not evident in previously reported macroscopic dose-response curves (82). 
One can picture the second ligand binding site as a poor complement to the ligand when the channel is closed, 
forming incomplete contacts with the ligand and therefore becoming more easily dislodged. If the channel 
opens, the binding site changes its configuration to complement better the structure of the ligand, and thus 
strengthen the ligand-receptor contacts (82). 
In summary, three fundamental steps appear to be involved in the transduction process: (a) ordered binding 
of two Ach molecules to the a-subunits at the receptor site that controls the formation of transmembrane 
channels. (b) The conformation of the receptor changes from a closed-channel state to an open-channel state 
that allows ions to flow through the receptor channel, and (c) a conformational change of the receptor, from 
an active to an inactive (desensitised) form occurs, due to the continued presence of an agonist (3, 84). 
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The channel is said to be either open or closed i.e. "an all or nothing event" (3, 4). The mean open time of the 
channel depends on temperature, membrane potential, location in cell membrane and on the agonist. Values 
of 0.9 ms for carbamylcholine and 2.4 ms for acetylcholine have been cited (3). The fraction of the time for 
which the channel is open (7) increases with increasing concentration of agonist indicating that channel opening 
is closely linked to agonist binding (1, 85). 
1.5.2.1.3 Role of Ca2 + and the ion-channel 
There is no doubt that the ion-channel is an integral part of the ai8;r,qpeotameric structure of the receptor (3). 
The channel is selective to cations and is a water-filled pore; permeating ions probably interact almost 
exclusively with water ions rather than with protein side chains (3). 
Triggle's work, c.i:ted m (6), on the guinea-pig ileum led them to suggest that the intrinsic activity of an 
agonist was a direct reflection of its ability in the agonist-receptor complex to activate the membrane-bound 
ca2 + translocation system. The source of mobilised ea2 + was uncertain at this stage but later developments 
ascertained that the receptor has a very high affinity for ca2 + ions and therefore, these ions played a role in 
receptor-ligand interactions. Prinz and Maelicke (86) established that binding of ca2 + inhibited receptor 
binding of a fluorescent ligand with an inhibition constant (Ki) in the mM range. It is now known that for every 
acetylcholine molecule bound, 2 - 3 ca2 + ions are displaced, suggesting a direct responsible role in receptor-
mediated permeability changes (6). One view is that ca2+ release results in a change in the dipole moment of 
the ion-channel leading to opening (6). 
1.5.2.1.4 Desensitisation phenomenon 
The term desensitisation, first used by Monod in 1963 for describing allosteric interactions of regulatory 
enzymes, is a totally different phenomenon from what neuropharmacologists describe today (87). 
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Desensitisation is the loss of response to a previously effective dose of agonist. It results from exposure to a 
high dosage of agonist or prolonged exposure to low depolarising dosage. It occurs in response to externally 
applied acetylcholine or other ligands or by excessive nerve stimulation (6). Whereas for receptor activation, 
where two agonist molecules are necessary, binding of only one molecule is sufficient for desensitisation. 
The following scheme outlines this :-
R+ L~RL+L~RL2-+AL2 
jf Jl 
DL DL2 
where R - receptor resting state 
L- ligand (agonist) 
A - active receptor, channel open 
D- desensitised receptor, channel closed (3). 
The rate and extent of desensitisation varies with the structure and concentration of agonist used and is 
enhanced by ca2+ and other cations as well as by high temperature (6). Desensitisation is known to occur 
within tens of milliseconds, allosterically shifting the receptor into a stable state that does not conduct ions, but 
binds agonists with increased affmity (15, 88). At least two such "desensitised" states have been described, with 
affinities for acetylcholine in the range of lp M to 10 nM respectively, as opposed to 100 J.lM for the non-
desensitised state (15). Solubilisation of membrane-bound nAChR also converts them into a desensitised fonn 
(15), suggesting that most binding studies involve desensitised nAChR's, rather than resting nAChR's. 
Four general functional states of the receptor can therefore be distinguished: resting, open, fast-onset 
desensitised, and slow-onset desensitised. The resting state is characterised by relatively low affmity and a 
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closed channel. The open state is an active state with channel open, affinity unknown or intermediate. The 
receptor desensitises in two steps, fast and slow; in each step the affinity for agonist increases by two orders of 
magnitude (89). This scheme is further complicated by the fact that the ion-channel may fluctuate between two 
distinct open states and even between resting and desensitised states which both represent closed-channel 
states. Katz and Thesleff, c.i.:ted in (!),proposed the following model: 
R A 
~I~ 
1l 
0 
Figure 1.6 Allosteric transitions proposed by Katz and Thesleff 
A - active state, channel open. 
I and D - rapidly and slowly desensitising states. 
The same two Ach sites are involved in each state, but 
their affinity varies from R to D via A and I. All 
these states are interconvertible, and, for some of them, 
present before ligand binding. 
The high concentration of agonist required to produce desensitisation would suggest that it occurs through 
binding to a low affinity site. It was therefore proposed that, in the membrane at rest, the receptor is present in 
a state with low affinity for agonists, and that agonists stabilised the receptor in a conformation having a high 
affinity for agonists, a conformation that corresponded to desensitisation of the system (6). 
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Whether stabilisation (6) or destabilisation (90) of the state occurs has yet to be clarified. The notion that, 
"ligand binding displaces bound water" and therefore, "it is the replacement of water by ligand'' that destabilises 
the closed state, appears to be acceptable (78, 82). 
Prinz and Maelicke (80) (1983) indicated from electrophysiological studies that two separate reaction 
sequences for receptor reactivation and desensitisution occur: both processes are reversible but, compared 
with activation, desensitisation requires longer periods of incubation of agonist and receptor. Neither 
formation nor breakdown of the desensitised state necessarily proceeds via the active form of receptor which 
supports the model proposed by Katz and Thesleff . 
Studies by Udgaonkar and Hess, in attempting to obtain information about the dissociation constants of the 
receptor-ligand complexes be.fore and after receptor desensitisation, and rate coefficients for desensitisation 
and recovery from it, showed, using a quenched flow technique that desensitisation actually occurred at 100 
times the rate estimated from electrophysiological techniques (83). Frog (Xenopus) muscle and Torpedo 
receptors exhibit an additional desensitisation process that occurs in the second-time region (83). 
Based on structural specificities of agonists, it has been suggested that the conversion from the low to high 
affinity state in vitro and receptor desensitisation involve the same molecular transition (91). Since the 
transition in receptor state can occur with ligands having widely different capabilities to activate the receptor, 
the relationship between receptor desensitisation and activation might be considered in terms of the respective 
rates of conversion in state for the various ligands (91). 
A disulphide-interchange model (92) proposed by Moore and Raftery is depicted as follows: 
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Figure 1.7 Disulphide - interchange model 
• 
car b - carbamylcholine 
resting state 
(low affinity) 
"desensitized" state 
(high affinity) 
The agonist binding site is now thought to be in the region of Gys 192 - Cys 193 (93, 94). Others have reported 
a readily reducible disulphide bond, 1 nm from the negative subsite of the Ach binding site (89). Thus, this 
disulphide appears to be intimately involved in the local conformational changes at the acetylcholine binding 
site leading to activation (94). The application of sulphydryl alkylating or acylating agents after disulphide 
reduction leads to irreversible modification of the receptor response (95) Recently, it was proposed (96) that 
the free cysteine is associated with a hydrophobic pocket in the receptor, which, when alkylated, blocks channel 
activity. 
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The interactions of forskolin, with the nAChR - ion channel complex has been studied (97). It was found that 
low concentrations (nM) induced receptor desensitisation but had no effect on the properties of Ach -
activated single channel currents, suggesting a mechanism of phosphorylation of the nAChR. Indeed 
phosphorylation of the nAChR could occur either in the resting state or in states with bound Ach. Such 
phosphorylation would enhance pathways leading to possible desensitised, non-conducting states (97). 
Desensitisation may not be evident under physiological conditions since the quantity of acetylcholine released 
during repetitive nerve flring does not appear likely to be sufficient to induce desensitisation. However, 
desensitisation of the receptor may serve as an autoregulatory function, protecting the region against excessive 
phosphorylation (97). It is known that protein phosphorylation by specillc protein kinases often have an 
autoregulatory role. 
More recently, it has been shown that acetylcholine also binds to a regulatory site, known as the isosteric site, 
inhibiting the formation of transmembrane channels. Isosteric inhibition (also known as voltage-dependent 
regulation), in combination with desensitisation appear important in the regulation of receptor function (84, 
98). 
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Isosteric regulation appears to occur on the same time scale as signal transmission, regulating the fraction of 
receptors in the membrane that can form transmembrane channels and thereby make the signal transmission 
process sensitive to small fluctuations in both transmembrane voltage and the concentration of acetylcholine 
(98). Similarly, fast-onset desensitisation regulates by blocking only a few percent of the receptors, but more 
importantly, because the rate of recovery is twenty-times slower than desensitisation itself, subsequent signal-
transmission is blocked to the extent that a critical concentration of receptors are only effective, determining 
whether a signal is transmitted or not. 
Finally, the effects of membrane perturbants on the receptor should be mentioned. Thermal perturbation 
studies using differential scanning calorimetry have shown that structural alterations of the receptor do occur in 
the presence of cholinergic agonists and that the release of free fatty acids by phospholipase A2 treatment from 
the membrane, result in destabilisation of the receptor and loss of conductivity upon exposure to agonists. 
Structural probes at the lipid/proteins interface also cause perturbations, in analogy with the release of "fluid" 
free fatty acids (14). Solubilising concentrations of detergents also produce a destabilised receptor, which in 
some cases can be reversed upon dialysis (17). 
Hence it can be seen that conformational changes of the receptor, which are vital to the functioning of the 
receptor can also become irreversibly altered states with an ultimate loss of activity devoid of any voltage 
depe~dency. 
'1.5.2.2 Antagonists 
1.5.2.2.1 Competitive 
Claud Bernard showed in 1856 that "curare", a South American arrow poison, caused paralysis by blocking 
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neuromuscular transmission ( 4). A specific curare agent, d-tubocurarine ( d-TbC) (figure 1.9 (i) R =H), the 
essential structure of which was established by King in 1935, has helped tremendously in elucidating many of 
the functional aspects of the nAChR. Until recently it was assumed to be a his-quaternary ammonium 
compound, however it is now known that one of the nitrogen atoms constitute a tertiary amine (37). A semi-
synthetic derivative, dimethyl tubocurarine (figure 1.9 (i) R = CH3) is almost three times as potent as d-TbC. 
Because of the large number of "curare"-like compounds and synthetic derivatives known, it will suffice to deal 
with only a few. 
CHi CH, OH 0-CH 6-CH,-oO-D > 
~O~CH,-o 
0 )=I /\ 
I OH CH, R 
CH, 
C
1 
H, CH, 
~ .,, 
H,C- 7-ICH,I10 -7-CH, 
CH, CH3 
O!camethonium 
ii 
d · Tubocurarine 
a · B ungarotoxin 
iii 
Figure 1.9 Antagonists of nAChR 
d-Tbc is a specific non-depolarising competitive neuromuscular blocking agent with little or no other actions, 
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other than interacting with the enzyme, acetylcholinesterase (37, 78). Many well-known alkaloids such as 
atropine, strychnine, quinine etc, show a marked increase in curaremimetic potency when their nitrogen atoms 
are quaterinised. Essential factors such as electrostatic attraction, steric influences, and the lipophilic-
hydrophilic balance of the molecule determines its activity (37). The concentration of charge on the nitrogen 
atoms also undoubtedly constitutes to potency. Optical isomerism is an additional factor; the d-form of 
tubocurarine being 20-60 times more potent than the 1-isomer. Bulkiness and rigidity of the molecules are 
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characteristic features, and the distance between the quaternary nitrogens (125 A for d-TbC) indicates a 
critical feature for curariform action. 
Synthesis of methonium compounds with varied polymethylene chain lengths (figure 1.9 (ii)) have helped in 
deducing the arrangement of the cholinergic site, which is now thought to be tetrameric (37). Thus the 
interaction of two anionic centres with antagonists appears to prevent any structural rearrangements of the 
receptor, normally associated with depolarising agents (agonises) (37). 
The snake venom toxins, a -bungarotoxin (see figure 1.9 (iii)) and cobratoxin have largely been responsible for 
the elucidation of the a-subunit of the receptor. The toxins are the "exceptions to the rule" in that they do not 
interact with acetylcholinesterase as do other nAChR ligands (78). Both are relatively small polypeptides (8 
kDa) and are classified as competitive antagonists in that they inhibit the regulatory activity of the receptor 
complex. Pharmacologically however, they are poorly understood due to their near-irreversible action. 
Interaction with nAChR monoclonal antibodies show five-toxin binding regions on the a-subunit, one region 
being that of the acetylcholine binding site (99). However it is not known whether the five toxin-binding regions 
form distinct binding sites or are faces of one binding site (99). Recently it has been conclusively shown, using 
monoclonal antibodies, that a -toxin binding overlaps with both d-TbC sites and agonist binding sites, and that 
the two a-toxin binding sites are non-equivalent (100). 
Binding of the classical antagonist, d-TbC, is complicated by the fact that two differing affinities occur for this 
ligand by the receptor, i.e. (two binding sites as for a-toxins and Ach but two different affinities) ( 44, 101, 102). 
It has been proposed that the two widely differing affinities, for eg. 20 nM and 5~M at equilibrium is a result of 
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the bifunctionality of the ligand showing a biphasic binding pattern, however other ligands have also shown this. 
No evidence has been obtained for an interaction of d-TbC with a site other than the Ach binding site ( 44). 
Agonist affinity alkylation of nAChR with bromoacetylcholine has provided evidence that the site which is 
easily labelled is the site with higher affinity for d-TbC, whilst the other low-affmity site for d-TbC shows lower 
reactivity towards bromoacetylcholine, and is only labelled under more extreme conditions (103). 
Direct binding of d-TbC to purified and membrane-bound nAChR has been studied in detail by Neubig and 
Cohen (102). They clearly showed that pretreatment with excess a-bungarotoxin or lOOp M cold d-TbC, 
completely blocked binding of radiolabelled d-TbC to the receptor; also the interaction between Ach and d-
TbC is simply competitive, once the two d-TbC binding affmities are taken into account. However the low-
affinity binding component of Ach necessitates very high concentrations of d-TbC (lOOpM) to produce total 
inhibition. 
The biphasic nature of binding of d-TbC is insensitive to conditions that alter equilibria between monomeric 
and dimeric forms (102). 
This same study identified a further binding component for d-TbC, that of a non-specific interaction with the 
membranes characterised as non-saturable (102). Interaction with the ion-channel in the presence of agonist 
has not been ruled out ( 4). The issue of whether d-TbC inhibits the receptor by competitive or non-competitive 
mechanisms has long been controversial and poorly understood (104). Measuring the rate of ion-flux prior to 
inactivations of the receptor over a wide range of ligand concentrations has shown that d-TbC inhibits both 
competitively and non-competitively (104). The two widely separate affinities involve the high affmity site, 
competitively inhibiting Ach binding and the other low affmity site, non-competitively. It seems likely that d-
TbC competes for both competitive binding sites and in the absence of agonist does not result in any detectable 
activation or inactivation of the receptor (104). Evidence has been presented suggesting that d-TbC binds to 
the same non-competitive inhibitory site on active receptors as cocaine, and not exclusively with the open-
channel form as previously postulated (104). 
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The multitude of effects of acetylcholine and antagonists can be viewed as follows:-
The inhibitory site is different from the regulatory site for activating ligands. Inhibitors binding to the inhibitory 
site may affect the rate of receptor inactivation ( desensitisation) or have no effect on the rate of inactivation ( d-
TbC). In addition, an inhibitor like d-TbC can bind both to the inhibitory site and the channel-activating ligand 
binding site, i.e. acetylcholine binding site (104). 
Finally mention of a group of antagonists, called the metaphilic antagonists ~g. diphenyldecamethonium, 
convert the receptor to a higher affinity state ( desensitised). The rate of conversion appears to be independent 
of the ligands capacity to activate the receptor; enhanced blockage of receptors occuring in the presence of 
agonist (79, 89, 91). 
1.5.2.22 Non-Competitive 
The third class of cholinergic effectors, the non-competitive antagonists/inhibitors (NCI) are an extremely 
heterogeneous group of compounds (3, 15). They are defined as ligands that block the nicotinic permeability 
response without preventing the binding of agonists. 
They comprise, aminated local anaesthetics such as procaine, lidocaine, the alkaloid histrionicotoxin (HTX); 
the hallucinogen phencyclidine (PCP); the neuroleptic chloropromazine, the lipophilic cation triphenylmethyl 
phosphonium salt (TPMP + ); detergents below their critical micelle concentration and fatty acids; fmally 
alcohols and general anaesthetics (the latter are NCI because of their desensitising action, acting probably by 
affecting the lipid phase surrounding the nAChR) (3, 62). 
The following properties are exhibited by many of these compounds: (a) permeation through the open 
channel, (b) increased antagonistic effect in the presence of increasing amounts of agonists; voltage-sensitivity 
of antagonism, thought to reflect the effect of transmembrane voltage on these charged compounds as they 
penetrate the channel, (c) decrease of the mean channel open time; (d) occupation of a single site per 
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nAChR monomer in contact with all constituent subunits and trapping of the ligand inside the channel on 
closing before dissociating (1, 15,89, 105). 
Two properties that appear to prevail amongst these compounds are the positive charge and hydrophobicity, 
suggesting certain structural requirements for binding to the NCI binding site (66). Tertiary amine local 
anaesthetics have pKa's in the region of 8-9 and therefore bear positive charges at physiological pH (105). 
Benzocaine, an uncharged local anaesthetic only slightly decreases agonist-induced currents (105). It appears 
therefore that voltage affects the relative potencies of local anaesthetics in blocking agonist-induced currents. 
At low negative membrane potentials the potency of the anaesthetics parallels their lipid solubility, but at high 
negative membrane potentials this correlation disappears. The results suggest a dual mode of action: an 
indirect interaction with the lipid surrounding the receptor, and a direct, voltage-dependent interaction with 
the receptor-channel complex (105, 106). The functional effects of the more lipophilic agents are poorly 
understood in comparison to the hydrophilic agents (93). 
Electron spin resonance has been used to contrast the accessibility of tertiary and quaternary local anaesthetics 
to their high affinity binding site in the desensitised nAChR (106). Two ligands, C6SLMel (permanently 
charged) and C6SL (pH-dependent charge of high hydrophobicity) (see below) have shown the following: 
(a) A charged gate in the channel mouth, presumably restricting entry of 
permanently charged quaternary amine local anaesthetics to the NCI 
site in the desensitised receptor. Conversely, the uncharged form 
of the tertiary amine enters with no barrier, and after entering can 
re-establish its charged state, depending on local solvent polarity 
and pH, allowing it to bind. 
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(b) The uncharged form, C6SL, is able to penetrate the lipid bilayer and 
gain access to the ion-channel. The existence of this hydrophobic 
path of entry would suggest a delayed onset effect (106). 
C6SLMel C6SL 
In conclusion, NCI bind to sites regulating the ion-channel sterically or allosterically (3). 
1.5.3 Ligand accessibility and receptor dynamics 
Studies of the effect of a specific ligand on the conformation and dynamics of a protein molecule are of 
considerable interest. Most non-polar groups in proteins are buried in the interior of the molecule. However 
some are found on the surface or in pockets in proteins. These may form hydrophobic sites of interaction with 
small effector molecules, becoming exposed as a result of biologically significant conformational changes in the 
proteins or during the process of denaturation (107). 
Spectroscopic methods have been widely employed in studying these changes; intrinsic fluorescence, as well as 
fluorescence quenchers have proved potentially useful (107, 108). The advantages of using intrinsic protein 
fluorescence in studies are twofold: Firstly there is minimal perturbation of the system; and secondly, natural 
ligands can be used at high concentration without loss of specificity or sensitivity (109). 
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The nAChR of electric organs has strong intrinsic fluorescence due to its content of 1.4-2.4 mol% L-
tryptophan. When excited at 290 nm, the receptor emits fluorescence with a maximum at 336 nm (6). The 
binding of neurotoxins to nAChR induces a fluorescence change of the receptor because the decrease in 
fluorescence intensity is much larger than the intrinsic fluorescence of neurotoxin itself. This change is thought 
to involve a conformational change, enhancing the affmity of the neurotoxin and the receptor by an optimum 
rearrangement of their local structures and/or allowing them to produce a mutually locked complex ( 40). 
It is well accepted that agonists cause a conformational change of the receptor, and therefore, would alter the 
intrinsic fluorescence of the receptor ( 40). However, there are many contrasting findings as to whether 
interacting cholinergic ligands induce fluorescenc~ changes or not. No changes in intrinsic fluorescence have 
been reported (90); small changes (4-10%) with agonists (110) and others suggest more marked changes with 
agonists and antagonists ( 40). It is important to bear in mind that regulatory functions of the receptor observed 
in vivo might be lost upon solubilising (110), and as previously stated, the formation of an inactive solubilised 
receptor complex. 
Kaneda, N. et. al. (110) suggest a 7-8% decrease in fluorescence on binding acetylcholine; 4-5% with 
carbamylcholine and no change with d-TbC or decamethonium. They observed maximum emission at 345 nm, 
in contrast to 336 nm previously reported (6, 90), suggesting a hydrophilic rather than hydrophobic 
environment. 
The dynamics of proteins (i.e. fluctuations that facilitate the penetration of a ligand or quencher) will always be 
coupled to and damped by the surrounding solvent (108). Solvent viscosity is thought to influence the rate of 
formation of protein complexes (111). 
Figure 1.10 
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Fluorescence quenching: Dynamic quenching of a fluorophore 
buried inside the protein globule requires diffusion inside 
the globule through densely packed groups of atoms (112) 
In addition to sensing the degree of exposure of tryptophanyl residues, quenching studies can be used to reveal 
certain details concerning the microenvironment of the residue; for example, altering the pH can result in 
modifications of amino acid side chains and hence altered interactions. It appears then that the accessibility of 
buried chromophores of proteins to quenchers is based on the dynamic perturbation in protein structure (the 
dynamic accessibility). These structural perturbations are assumed to be governed by some diffusion - limited 
processes in the solvent surrounding the protein molecule (112). The fact that at least one tryptophanyl residue 
exists at the region neighbouring the binding site for cholinergic ligands allows one to further investigate the 
nAChR. 
CHAPTER2 
ISOLATION AND PURIFICATION OF. THE NICOTINIC 
CHOLINERGIC RECEPTOR 
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2.1 INTRODUCTION 
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The nicotinic cholinergic receptor of the ray, Torpedo fuscomaculata, has,as yet not been isolated and purified. 
Although few species differences have been noted by our overseas counterparts (5), it nevertheless provided an 
opportunity to study the structural and functional aspects of this receptor complex. 
A pre-requisite for obtaining receptor preparations functioning both in ligand recognition and ion-channel 
gating is a purification under conditions which protect the receptor from proteolytic attack (11, 25). 
Homogenisation of the electroplax tissue in the presence of ethylene diamine tetraacetic acid (EDTA) and 
sulphydryl blocking agents such as N. ethyl maleimide or iodoacetamide has been recommended (11). While 
this procedure apparently preserves the chemical integrity of the receptor protein, this may not necessarily be 
the case for its functional integrity (13). 
Current techniques for the preparative isolation of proteins use the chromatographic recognition of a variety of 
physical parameters. The ideal separation method employs an easily identifiable physical parameter unique to 
the protein of interest (113). Gel filtration, affinity chromatography with biospecific or group specific 
adsorbents, ion-exchange chromatography and preparative electrophoresis have proved to be versatile 
separation techniques. Seldom does any one of these procedures provide sufficient resolution or 
characterisation to obtain a homogeneous protein from a complex biological material. For this reason 
purification procedures normally combine some or all of these techniques to increase purity in a series of 
chromatographic/ electrophoretic steps. 
It should be noted, that unlike the isolation of proteins with enzymatic function where the activity of the enzyme 
can be monitored throughout a purification, receptor isolation is accompanied by a concomitant loss of 
physiological activity, a process dependent upon the integrity of its membrane components (5). 
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As part of a study in our laboratories on the nicotinic cholinergic receptor it has been our intention firstly, to 
improve upon the purification of the receptor and secondly, with the advent of new and improved products for 
protein purification, to re-focus our attention on the classical biochemical techniques such as ion-exchange 
chromatography and chromatofocusing. Finally, purification by these methods and those of affinity 
chromatography allow for a comparison of the techniques. 
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2.2 MATERIALS AND METHODS 
2.2.1 Materials 
All reagent solutions were freshly prepared in doubly distilled!deionised water or appropriate buffer. 
Buffer-solutions (114): 
Tris-HCI (0.1 Mil at pH 6.6; 7.6 and 8.8). Sodium phosphate (0.1 Mil, pH 8.0). Sodium acetate (0.1 MJ1, pH 4.0 
containing 0.5 Mil NaCl) and Imidazole-HCl (0.025 M/l, pH 7.4) were prepared. 
Reagents 
Pure Naja Naja venom (tt-cobratoxi.n) was purchased from the Council for Scientific and Industrial Research, 
Pretoria, South Africa. 
Sodium azide and ethylenediamine tetraacetic acid (EDT A) were obtained from Aldrich Chemical Company, 
Ltd. Gillingham, England. 
Tween-20 and Coomassie brilliant blue were obtained from Merck, Darmstadt, West Germany. 
Polybuffer exchanger (PBE 94); Polybuffer 74; Sephacryl S-400, S-200 and cyanogen bromide Sepharose 4B 
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were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. 
Phenylmethylsulphonyl fluoride; carbamylcholine; DEAE-Sephadex A-50; DEAE-Sepharose 6B; sodium 
dodecyl sulphate; acetylthiocholine chloride; molecular weight standards and d-tubocurarine were obtained 
from Sigma Chemical Company, St. Louis, U.SA. 
Triton X-100; bromophenol blue and B -mercaptoethanol were obtained from BDH Chemicals, Ltd. Poole, 
England. 
Albumin fraction V (Bovine serum); 5,5-dithiobis-(2-nitrobenzoic acid (DTNB) and acetylcholinesterase were 
obtained from Boehringer Mannheim, West Germany. 
I I 
N, N, N, N-tetramethylenediam.ine (TEMED); acrylamide and N,N- methylene-bis-acrylam.ide were obtained 
from Fluka AG, Chemical Fabriek, Switzerland. 
Dialysis membrane tubing with molecular weight cut-off 6000-8000 Da was obtained from Spectropor, Los 
Angeles, U.SA. 
Ammonium sulphate and ammonium persulphate were obtained from Koch-Light laboratories Ltd. South 
Africa. 
Glycine was obtained from Saarchem (Pty) Ltd. South Africa. 
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2.2.2 Methods 
Live electric rays (Torpedo fuscomaculala (115)) (see figure 2.1) were caught in the Bushman's estuary off the 
South East coast of South Africa by the author. Figure 2.2 shows the necessary equipment and figure 2.3 a 
Torpedo ray demonstrating its defence mechanisms. 
Figure 2.1 Figure 2.2 
Figure 2.3 
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2.2.2.1 Extraction of Receptor 
Electric organs were excised from a freshly killed Torpedo ray and stored at -80°C until required. Electric 
tissue (120 g) was homogenised (2 minutes) in either imidazole buffer (0.025 M/1, pH 7.4, 150 cm3) or Tris-HCI 
buffer (O.lM/1, pH 7.6, 150 cm3) containing phenylmethylsulphonyl fluoride (0.1 m.M), EDTA (10 m.M) and 
sodium azide (0.01%) (8). The homogenate was then centrifuged (20 000 x g, 60 min, 4°C) and the supernatant 
discarded. The pellet was resuspended in the same buffer solution and Triton X-100 added to a final 
concentration of 1%. The mixture was stirred (18 h, 4°C) and then centrifuged (100 000 x g, 60 min, 40C), the 
pellet resuspended in the above buffer, centrifuged again and the supernatants pooled. Receptor activity and 
protein content were determined. 
2.22.2 Affinity Chromatography 
The affinity resin CNBr-activated Sepharose 4B ( 40cm3) was incubated with tt-cobratoxin (15 mg) for 18 h at 
4°C (29). This was treated with 0.2 Mil glycine pH 8.0 and then washed alternatively with coupling buffer 
(NaHC03 0.1M, pH 8.3 containing 0.5 M NaCl) and acetate buffer (0.1 M, pH 4.0 containing 0.5 M NaCl). 
This was poured into a column (7.5 x 2.6 ems) and washed with Tris-HCl (0.1 M/1, pH 7.6). 10 cm3 of partially 
purified receptor material was allowed to filter through the gel matrix. After all the receptor material had been 
applied, an incubation period of 2 hours at 20°C was allowed. Three washing cycles were then used to 
remove unwanted material: extraction buffer containing 0.1% Triton X -100 alteniating with 1M N aCl. 
Fractions (3.0 cm3) were ~ollected and monitored for absorbance at 280 nm. Carbamylcholine (1M, 20 cm3) 
in Tri.o;-HCl buffer was then passed into the column, incubated (5 hours) and fractions (3.0 cm3) collected and 
monitored for absorbance at 280 nm. Receptor activity, enzyme activity and protein content were determined 
(6, 8}, 
I 
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2.2.2.3 Ion-Exchange Chromatography 
The resins (DEAE · Sephadex A-50 and DEAE · Sepharose 6B) were equilibrated in Tris-HCI buffer (0.1M/l, 
pH 7.6) and poured into separate columns (10 x 2.6 ems). The partially purified receptor (10 cm3) in Tris-HCl 
buffer (0.1 Mil) was ftltered through the gel matrix at a rate of 80 cm3/h, fractions (3.0 cm3) collected and 
monitored for absorbance at 280 nm. After all the receptor solution had been applied the column was washed 
with Tris-HCl buffer (0.1 M, pH 7.6) until the absorbance of the effluent had dropped to base-line levels. A 
linear gradient of sodium chloride was then started with a flow rate of 80 cm3/h, fractions (3.0 cm3) collected 
and monitored for absorbance at 280 nm. Receptor activity, enzyme activity and protein content were 
determined. 
2.2.2.4 Chromatofocusing 
The receptor extract (10 cm3) in imidazole buffer (0,025 M/1, pH 7.4) was added to a chromatofocusing column 
(11 x 1.6 ems) previously equilibrated and washed successively with imidazole buffer (0.025 Mil, pH 7.4) and 
Polybuffer 74 (5 cm3, pH 4.0) (27). The column was eluted with Polybuffer 74 (200 cm3, pH 4.0) at 54 cm3/h, 
fractions (3.0 cm3) collected and monitored for absorbance at 280 nm. Finally the column was washed with 
sodium chloride (1M, 50 cm3) to elute proteins not displaced by low ionic strength. Receptor activity, enzyme 
activity and protein content were determined. 
A pH calibration curve was prepared using cytochrome C (pi = 10.1) (8 mg) and Bovine carbonic anhydrase 
(pi = 6.57) (8 mg). 
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2.2.2.5 Ammonium Sulphate Fractionation 
Ammonium sulphate was added to the receptor active fractions from each of the affinity chromatographic, ion-
exchange and chromatofocusing stages. 100% saturation was achieved, stirring on ice for 3 hours. The 
precipitate was collected by centrifugation (10 000 g/ 10 mins) redissolved in Tris-HCl buffer (0.1 ?v[Jl, pH 7.6, 
1.0 cm3), dialysed against the same buffer (21, 4°C, 4 h) and finally lyophilised. 
~.2.2.6 Molecular weight determinations 
(a) Gel chromatography 
The molecular weight of the material obtained from the different methods was determined by chromatography 
on Sephacryl S-200 and S-400 in Tris-HCl (0.1MJ1, pH 7.6). The S-400 column (40 x 1.6 ems) was standardised 
with Blue dextran (2 x 106 Da), lactate dehydrogenase (140 000 Da), DNase (63 000 Da) and carboxypeptidase 
A (34 300 Da) (Appendices 1 and 2). Purified material (15 mg) in 1.0 cm3 was applied to the column and 
eluted with the same buffer, at a rate of 33 cm3!h, fractions (3.0 cm3) collected and monitored for absorbance 
at 280 nm. The S-200 column (30 x 2.6 ems) was standardised with the above standards excluding DNase at a 
flow rate of75 cm3/h. 
(b) Disc-Polyacrylamide gel electrophoresis 
Electrophoresis of the purified material was carried out using the Laemmli method ( 45) on SDS slab gels. 
Resolving gel (10%) and stacking gel (4%) were prepared from the acrylam.ide-bis acrylarnide mixture in 0.1 
Mil Tris-HCl, pH 8.8 and pH 6.8 respectively, polymerised using 0.025 % TEMED and ammonium persulphate 
(1.5% W/V). The upper and lower buffer compartments were filled with 0.1% SDS - TRIS-HCl buffer. 
Standards ovalbumen(45 000 Da), BSA (68 000 Da) ,catalase (6.0 000 Da), LDH (36 000 Da) and 
carboxypeptidase A(34 300 Da) were used at 1 mg/ cm3 to prepare a standard curve (appendix 3). 
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The sample (50~) was treated with dissociation buffer (50~) and applied to the gel. A potential of 100 mY 
was applied for 30 min and then 150 m V for 3 h until the tracking dye was within 5 mm of the bottom of the gel. 
Protein was stained with a 0.2 % solution of Coomassie Blue in a mixture of methanol-water-glacial acetic acid. 
Destaining was achieved by extensive washing in methanol-water-glacial acetic acid. The gels were vacuum 
dried (4h) and stored. 
2.2.2.7 Protein Determination 
Protein content was determined by the modification of the Lowry method {116) using bovine serum albumen as 
the standard (appendix 4). 
2.2.2.8 Assay for acetylcholinesterase 
The method of Ellman (117) was used. Acetylthiocholine is hydrolysed by AChE to acetic acid and thiocholine, 
which then reacts with DTNB (see materials) to form a yellow anion. The increase in absorbance is monitored 
spectrophotometrically at 410 nm. 
2.2.2.9 Assay for Receptor 
A fluorescence titration assay is described here which allows a rapid and reproducible means for determining 
receptor concentrations without many of the difficulties associated with the use of radiochernicals (102). d-
Tubocurarine, a specific competitive antagonist of the nAChR, shows similar affinities for both membrane-
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bound and solubilised receptor and hence includes its use as a fluorescence quenching ligand (24). Since the 
excitation light decreases along the path due to the absorption by d-TbC, the decrease in the tryptophanyl 
fluorescence is corrected by dividing the apparent intensity (Fa) by the light intensity in the sample cell, as 
Fe = Fa/lOEca 
where Fe is the corrected fluorescence intensity, E and c are molar extinction and molar concentration of d-
TbC, and "a" is an instrumental constant which was found to be 0.588 (110). 
Fluorescence measurements were made using a Hitachi fluorescence spectrophotometer with excitation light 
source from a Xenon 150 lamp. The spectra were taken at an angle of 90° to the exciting light. A quartz 
cuvette consisting of sample (3.0 cm3) in appropriate buffer was titrated against increasing d-TbC 
concentrations until Fe reached a maximum indicating saturation of binding sites and hence concentration of 
receptor. An excitation wavelength of290 nm and emission wavelength of340 nm were chosen. 
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2.3 RESULTS 
2.3.1 Extraction of Receptor 
The non-denaturing detergent Triton X-100 was effective in solubilising the receptor after an incubation period 
of 18 h. From an initiall20 g of electric organ, 2.52 g of material was removed by low speed centrifugation with 
a specific activity of 0.53l!M/g. High speed centrifugation, in the presence of Triton X-100, resulted in 1.41 g of 
protein with a specific activity of 0.84lM/g. This gave a 30% yield of semi-purified receptor material. 
2.3.2 Affinity Chromatography 
Extraneous protein material was removed by adding alternatively Tris-HCl buffer/0.1% Triton X-100 and 1 M 
NaCl (elution profile not shown). 
Carbamylcholine proved successful in recovering free nAChR from the Sepharose column in 20 cm3. 76 mg of 
protein with a specific activity of 3.03 llM/g was recovered. The receptor active fractions were found to be 
devoid of any enzyme activity. 
Affinity chromatography results in a 7.1 fold purification and a 5.84 % yield. Saturation with ammonium 
sulphate and lyophilisation improved this fold purification to 12 with a 1.5% overall yield and 5 JJM/g specillc 
activity. 
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Figure 2.4 represents a gel chromatogram for the determination of the molecular weight of the purified 
receptor on a Sephacryl S-400 column. A major broad band with a peak maximum at 57 000 :!:' 1000 and Ve of 
81 cm3 is present. A small amount of material ( 400 000) appears in the void volume (V 0 = 31 cm3) 
(Appendix 1) 
Figure 2.5 is an electrophoretogram of SDS-PAGE analysis of the purified receptor. Three major bands are 
prominent (i) 66 000 ± 1 000; (ii) 63 000 ± 1 000 and (iii) 40 000 ± 1 000. A minor band appears at 52 000 
± 2000. 
2.33 Ion-Exchange Chromatography 
It can be seen that the receptor adsorbs tightly to the anion-exchange gel (figure 2.6). Removal of extraneous 
protein and Triton X-100 is achieved at low ionic strength. Increasing the NaCl concentration produced two 
peaks, the first of low receptor activity corresponding to a low molecular weight species of about 36 000 while 
the second (0.6 M NaCl) had higher activity. Fractions of the second peak (24 cm3) consisted of 60 mg of 
protein with a specific activity of 2.0 }.llv!/g. This fraction was found to have negligible enzyme activity. 
Other ion-exchange resins such as DEAE-Sephadex A-50 were found to be totally inadequate in purifying the 
receptor protein. They gave broad elution peaks over a wide range of ionic strength with poor resolution. 
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Ion-exchange chromatography gave a fold purification of 5.0 and a 3% yield. Saturation with ammonium 
sulphate and lyophilisation increased the fold purification to 7 with a 1% yield. The specific activity was 3~/g. 
Figure 2.7 shows the gel chromatogram on Sephacryl S-400 and figure 2.8 the SDS-PAGE electrophoretogram. 
In figure 2.7 two major molecular weight species are observed- 125 000 ± 1000 at 72 cm3 Ve and 44 000 ± 
1000 at 88 cm3 Ve. A minor peak at 81.5 cm3 Ve represents a 66 000 component and a small peak in the void 
volume accounts for receptor dimer. The electrophoretogram in figure 2.8 shows several bands- (i) 66 000 ± 
1000; (ii) 63 000 ± 1000; (iii) 53 000 ± 1000 and (iv) 40 000 ± 1000. Bands below 40 000 and between 80 
000 and 100 000 are also present. 
2.3.4 Chromatofocusing 
The results of the chromatographic separations are shown in figure 2.9. It can be seen that the removal of 
Triton X-100 and extraneous protein occurs rapidly. Elution of the active receptor in a sharp peak is readily 
accomplished by a step increment in ionic strength to 1M NaCI. The chromatofocusing step (16 cm3) consisted 
of 132 mg of protein with a specific activity of 3.2 ~M/g. 
The pH of the receptor active fractions was found to be 5.16 (not shown in figure 2.9) indicating the need for 
an increase in ionic strength for elution of receptor protein. A 7.5 fold purification and a 10% yield is 
improved to a 12.5 fold purification and a 2.3% yield after ammonium sulphate treatment and lyophilisation. 
Negligible enzyme activity was indicated. 
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The gel chromatogram (figure 2.10) demonstrates 3 major peaks- 123 000± 1000 at 73 cm3 Ve; 63 000 .:!" 1000 
at 81 cm3 Ve and 56 000 ± 1000 at 82.5 cm3 Ve. A minor peak at 89 cm3 Ve represents a 40 000 molecular 
weight unit. Two smaller peaks, one in the void volume represents receptor dimer and another at 65 cm3 Ve a 
molecular weight of 230 000. 
SDS-PAGE analysis (figure 2.11) shows several bands (i) 95 000 -100 000; (ii) 66 000 ± 1000; (iii) 63 000 ± 
1000; (iv) 53 000 ± 1000 and (v) 44 000 ± 1000. Other bands present are those of (vi) which represents 
material of 8000 - 10 000 molecular weight and 2 - 3 bands between 75 000 and 95 000. 
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2.4 DISCUSSION 
The electric organ of the Torpedo ray is advantageous for the isolation of the nicotinic cholinergic receptor 
because it represents a homogeneous high density population of synapses all of which use the cholinergic 
mechanism. The electric organ is also the richest source of acetylcholine receptor known (1, 5). 
Freezing and thawing of tissue was kept to a minimum during the extraction procedures since the probability of 
proteolytic attack by intracellular proteases during these cycles is great (7). No noticeable differences were 
observed however when organs which had been stored at -20°C for several months, were used instead of fresh 
ones. 
The high affinity and specificity of the a-neurotoxins for the receptor (18) facilitate the removal of unwanted 
material on an affinity chromatographic system. Only 5-10% of the toxin retains its ability to bind receptor 
protein (5, 9, 12, 22, 28), resulting in a low recovery. 
The amount of receptor protein recovered compares well with 4-6 mg from 200 g (8). A 5.0 1-lM/g specific 
activity is also in agreement with the literature (2.0-12.0 llMig) (2, 6, 36, 38). It should be noted that the activity 
of the receptor preparations have been monitored by the receptors ability to quench the fluorescence of d-TbC 
and not that of the a-neurotoxins. The slightly lower specific activity is possibly due to some non-specific 
interactions between d-TbC and the crude-receptor extract. 
A fold purification of 7.1 is low in comparison to other reported findings. After ammonium sulphate treatment 
and lyophilisation there was an increase in purification to 12-fold which is in agreement with the literature (5). 
It is reasonable to suppose that the popularity of affinity chromatography stems from its ability to achieve high 
fold purifications of proteins. Disadvantages are clearly the low recovery of receptor material (5.84% yield), 
the time taken to perform affinity chromatography (2 days) and possible modified binding properties of the 
protein once recovered (25). 
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Estimation of the molecular weight of the receptor protein under non-denaturing conditions revealed a small 
amount of receptor dimer linked through a disulphide bond between 6-6 subunits. This is to be expected since 
the receptor exists in a dimeric state in the membrane (13). The absence of monomer units (250-270 kDa) (2, 
3, 11) appears to indicate proteolysis of receptor material into individual subunits. This is surprising since 
maximum precautions were taken. All solutions contained Triton X-100, for preventing aggregation of receptor 
protein, and certain protease inhibitors such as EDT A and phenylmetbylsulpbonyl fluoride. Sodium azide was 
also included to inhibit bacterial growth. 
The broad band (figure 2.4) at 81 cm3 Ve indicates poor resolving power of the system. Investigation of the gel 
chromatograms of both ion-exchange and chromatofocusing however suggest this not to be the case. It appears 
to indicate a number of subunits that are intimately but non-covalently associated. 
Under denaturing conditions, i.e. in the presence of SDS, the 6-subunit (66 kDa),-y -subunit (63 kDa) and a-
subunit ( 40 kDa) are represented. The sensitivity of the ~subunit (53 kDa) to degradation is evident. 
Purification of the receptor by ion-exchange chromatography bas in the past proved poor in comparison to 
techniques such as affinity chromatography. Elution of receptor protein in the presence of 0.5 M NaC~ using 
DEAE-Sephadex A-25 in conjunction with affinity chromatography, had proved however more advantageous 
(5, 22). DEAE-Sepharose 6B (an anion-exchange gel) has shown that recovery and purification of receptor is 
nearly as efficient as affinity chromatography. This, and the fact that poor resolution was obtained using 
DEAE-Sephadex A-50, clearly demonstrates an improved product for protein purification allowing for 
increased resolution. 
Recovery of 2.5 mg of protein at 0.6 M NaCl is only slightly lower than that of the affinity chromatographic 
step, however a 3 ~M/g specific activity reflects a lower fold purification. 
The removal of receptor protein material within the first peak (figure 2.6), indicates extensive proteolysis of the 
receptor in the absence of protease inhibitors and Triton X-100. It was envisaged that the increased ionic 
strength would minimise proteolysis and simultaneously prevent any clustering of receptor protein. The lower 
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recovery (1%) after ammonium sulphate and lyophilisation is therefore a result of proteolytic nicking, while the 
lower fold purification is due to the recovery of non-specific proteins with the receptor. 
Ion-exchange chromatography is inefficient in purification of proteins since it allows many proteins to elute 
under similar conditions and large volumes of eluting buffer are required to cause elution of receptor. 
Molecular weight determinations under non-denaturing conditions reveal receptor-dimer and a component of 
approximately 130 kDa ( 6-osubunits). This is in agreement with many other findings (11, 15, 43, 47). Similarly, 
as was found with affinity chromatography, receptor-monomer units are absent from the chromatogram. 
Increased presence of individual unit (figure 2.7) over those ·of figure 2.4 show that the extent of proteolysis was 
greater using ion-exchange chromatography than for affinity chromatography. The 6-subunit (66 kDa) and the 
a- subunit ( 44 kDa) are represented in the chromatograms. 
Under denaturing conditions, all four bands of the receptor are observed:a(40 kDa),6 (53 kDa),'Y (63 kDa) and 
6{66 kDa). The results, however, show considerable impurities whether by contamination of the gels (118) or 
by proteolytic action from within the receptor samples themselves. Even though the latter appears to be true 
the former possibility cannot be ignored. Samples could easily have been subjected to contamination during 
experiments and lyophilisation. Ochs (118) has reported many artifacts and confusing results observed on SDS-
PAGE due to contaminant proteins such as skin keratins. 
Another explanation of the heterogeneity of the gels is the concept that the nAChR protein is highly associated 
in the membrane with other specific binding proteins (22). Treatment with Triton X-100 might lead to co-
solubilisation such that the integrity of the protein-protein interactions are undisturbed. The nAChR can be 
eluted from the ion-exchange chromatography with the associated proteins still attached. 
The presence of a cytoskeletal element (43 K protein), which is functionally associated with the receptor (48), is 
also suspected. 
Of the classical biochemical techniques, isoelectric focusing had proved to be the best for purifying the 
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receptor protein achieving a 6.3-fold purification (28). Chromatcfocusing provides an alternative and offers 
advantages in that: (a) no special equipment is needed, (b) the method saves time, (c) no problems exist with 
cooling, (d) special care is taken to attain low optical density in the buffers used and so rapid removal of Triton 
X-100 and extraneous protein, and (e) different proteins are separated according to isoelectric points without 
cross contamination. 
The use of 1 M NaCl proves useful in that clustering of receptor monomers is prevented in the absence of 
Triton X-100, furthermore it allows rapid recovery with small volumes of the protein. The fact that the 
receptor protein does &ot elute during the salt gradient is because of its low pi value and also its tendency to 
adsorb to the gel. One would require an extremely low pH to elute this protein at low ionic strength buffer. 
Recovery of 6 mg of receptor protein of 5.5 J..tM/g specific activity is better than that achieved by both affinity 
and ion-exchange chromatography and in good agreement with the literature (8). 
Molecular weight analysis under non-denaturing conditions reveals similar species to those from ion-exchange 
chromatography. This suggests that the purifications exhibit nearly identical patterns on Sephacryl S-4DO 
chromatography strongly arguing that a unique population of protein molecules is being selectively isolated. 
The presence of receptor monomer, even after extensive proteolysis, indicates an increased amount of purified 
receptor material. This is not surprising since a step-increment in ionic-strength facilitates removal of all 
adsorbed receptor material in a small volume. All the subunits (a, 13, -y and 6} are represented with molecular 
weights in excellent agreement with other reported findings (2, 42, 44). That extensive degradation of the 
receptor has occurred is clearly evident in figure 2.10. The low fold purification and recovery is evidently 
related to the extent of proteolysis, since the activity of proteolytically degraded receptor monomer/dimer units 
would be very low. Competitive antagonists, such as d-TbC, preferentially interact with receptors in a resting 
rather than desensitised (inactive) receptors. 
Receptor material in the presence of SDS reveals the a ( 44 kDa), 13 (53 kDa), "( (63 kDa) and 6 (66 kDa) 
subunits. Similarly, as for ion-exchange chromatography, the presence of several bands indicates impurities 
whether by contamination or by proteolytic attack. The latter may possibly arise from incomplete inhibition of 
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the proteases during purification so that on SDS-PAGE electrophoresis only the a-subunits (40-45 kDa) are 
apparent (11). Nicking of the~. -yand 0-subunits might also account for the considerable number of minor bands 
in molecular weight range of 54-57 kDa and 65-68 kDa observed in the gel electrophoretogram. 
The presence of molecular weight units greater than 68 kDa indicates insufficient purity of the receptor 
preparation (3). Integral enzymes such as protein kinases and/or proteases are suspected. Units below 40 kDa 
i.e. (band (vi) figure 2.11) indicate severe proteolysis. This can be compared to the treatment of receptor with 
trypsin or chymotrypsin rendering components in the order of 8 kDa and less (6). 
A comparison of all three chromatographic procedures (i.e. ion-exchange chromatography, chromatofocusing 
and affinity chromatography) shows chromatofocusing to be more advantageous, firstly because of the time and 
cost that is saved and secondly, since all three methods use commercial Sepharose as the gel-matrix; nAChR 
adsorbing to the gel would be removed by 1M NaCI. Only tightly bound receptor-neurotoxin complexes would 
be retained in affinity chromatography resulting in extremely low recoveries. 
The disadvantages of both ion-exchange chromatography and chromatofocusing is that non-specific proteins 
are removed simultaneously with the receptor. Purification of proteins on the basis of their isoelectric points is 
superior to variations in salt concentrations. The difference in fold purification and recoveries of the two 
methods show this to be the case. 
The estimated degree of purity, based upon electrophoretic analysis, before and after chromatofocusing was 
judged to be greater than 90%. The extent of proteolysis however suggests the requirement of a "cocktail" of 
protease inhibitors present throughout the purification. For chromatofocusing and ion-exchange 
chromatography dilution of these inhibitors has occurred resulting in the observed electrophoretograms. 
The fact that cloning of the receptor has recently been made possible (15), has allowed an accurate assessment 
of the subunit molecular weights of the receptor; a-subunit (50116 Da), ~ (53681 Da), -y (56279 Da) and 6-
subunits (57565 Da). The differences between these values and those of SDS-PAGE are best explained by the 
amount of glycosylation (10-11% on subunits) and detergent present (Triton X-100)-(11 %). Since both add 
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weight to the subunits, the differing molecular weights reported by the three methods can be attributed, flrstly 
to these factors and also to the characteristics of the individual techniques for purifying the receptor. 
From chromatofocusing a pi value of 4.5-5.0 can be assumed for the receptor. Based on the strict criteria for 
assessing purity however, our findings reveal a heterogeneous receptor preparation. 
Whether a true receptor, (i.e. a protein with its essential functional associating elements) can be isolated, is not 
completely satisfied. Chromatofocusing in the presence of substantial protease inhibitors, proves to be the 
method of choice for purifying the receptor. 
CHAPTER 3 
PHOTOCHEMISTRY OF NITROSAMINES AND 
RECEPTOR - LIGAND INTERACTIONS 
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3.1 INTRODUCTION 
Research in our laboratories and others (69) has shown the nitrosamines to be weak competitive inhibitors of 
acetylcholinesterase. Like most acetylcholinesterase ligands the nitrosamines should therefore interact with the 
receptor (85). 
Their potential in photoaffmity or energy-transfer labelling has been discussed in chapter 1 . The criteria, 
necessary for active site labelling by photoaffmity or energy-transfer mechanisms appear to be met by these 
compounds. 
It was envisaged that these compounds and/or derivatives might improve detection of the solubilised receptor 
through covalent linkage of residues at the acetylcholine binding site. It was hoped, depending on the 
specificity and reactivity of these ligands, that an improved purification of the receptor could be achieved. 
In this chapter, the chemistry of the nitrosamines is dealt with frrstly. Secondly, the interaction with semi-
purified and purified receptor material and finally the proposition of synthesising and preparing derivatives of 
these compounds. The aim: that of a highly specific and photosensitive ligand of low Kd and with considerable 
structural rigidity such that it possesses the geometrical requirements for receptor activation. 
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3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Buffer solutions (114): 
Tris-HCl (0.1 M/1, pH 7.6) and Imidazole-HCI (0.025 Mil, pH 7.4) 
Reagents 
Dimethylnitrosamine (DMN) was obtained from Eastman Kodak Company, Rochester, New York, U .S.A. 
Purity checked by infra-red spectroscopy. 
Acetylcholine chloride and diphenylnitrosamine (DPN) (mpt. 66-67°C) were obtained from Sigma Chemical 
Company, St. Louis, U .S.A. 
Trifluoroacetic acid was obtained from Holpro Analytics (Pty) Ud. South Africa. 
3.5 dinitrobenzoylchloride was obtained from Merck, Schuchardt, West Germany. 
- Electric organ acetone powder (Electrophorus electricus) was purchased from Sigma Chemical Company, St. 
Louis, U.S.A. A 1% Triton X-100 extract was prepared by centrifuging at 10 000 x g/10 mins at 4oc. The 
p ellet was discarded and supernatant kept for further studies. 
All other reagent solutions were prepared as in chapter 2. 
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3.2.2 Methods 
3.2.2.1 Spectroscopy and Photolysis 
A multiwavelength Bausch and Lomb 1001 Spectrophotometer measured the changes in absorbance of 
dimethylnitrosamine and diphenylnitrosamine at U programmed wavelengths from 230 nm to 380 nm. 3.0 cm3 
samples in a quartz cuvette, consisted of DMN (454pM/l) or DPN (100pM/l), heptane and CF3COOH (0.43 
M/1). A reference cuvette contained heptane and/or CF3COOH for determining the absorbance of DMN and 
DPN. 
A similar scan was performed using a Beckman U.V. 5240 with dual reference and sample holders allowing an 
accurate determination of maximum and minimum absorbances with graphical display. 
The U.V. spectra of DMN (136 mM/1) in imidazole buffer (pH 7.4) and in dilute acid (pH 1-3) were examined 
using the 1001 Spectrophotometer. Irradiation of these 3.0 cm3 samples for 5 mins and 30 mins was carried out 
with a 125 W Hanovia (Hg) lamp (Slough, England), placed at a distance of 5 em from the quartz cuvette. 
Fractions consisting of suspected active receptor from the chromatofocusing column (chapter 2) were 
subjected to photolysis (5 mins) from the above lamp, in the presence of DMN (2.83 mM/1). Control and 
experimental samples (3.0 cm3) were observed spectroscopically as above. These same samples were then 
dialysed for 5 h against 0.025 M/1 imidazole buffer pH 7.4 and U.V. spectra recorded. 
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Partially purified electric organ acetone powder (20 mg) in 3.0 cm3 Tris-HCI buffer, pH 7.6 was suspended 
with 1% Triton X-100 or 1% Tween-20 (18 h, 4°C). This was centrifuged at 10 000 x g/10 mins and the 
supernatant retained. 100 pl samples (approximately 100 pglcm3) of receptor material and DMN (10 m.M/1) 
were treated as for the chromatofocusing-DMN samples as above. The irradiated and non-irradiated samples 
(3.0 cm3) were then applied to a Sephacryl S-200 colwnn (as in chapter 2), eluent monitored at 280 nm. 
3.2.2.2 Fluorimetry 
Fluorimetric observations of the receptors intrinsic fluorescence in the presence of DMN and other cholinergic 
ligands were investigated using the Hitachi fluorescence spectrophotometer ( cf. 2.2.2.9). Purified receptor 
material (100 ~cm3) in 3.0 cm3 was excited at 290 nm with emission at 340 nm. The absorption of d-ThC at 
this wavelength was taken into account ( cf. 2.2.2.9). 
3.2.2.3 Organic synthesis 
An attempt was made at derivatising DMN (100 mMJl) with 3,5 dinitrobenzoyl chloride (100 mM/1). The 
reaction was carried out in dry ethanol or tetrahydrofuran under nitrogen with stirring and heating (50°C). 
Samples were taken at various time intervals for a period of 72 h. Analysis was carried out using thin layer 
chromatography (TLC) (0.2 mm 60p254 aluminum sheets, silica gel; ethylacetate: hexane)(1:1). 
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3.3 RESULTS 
3.3.1 Photochemistry 
From table 3.1 it can be seen that dimethylnitrosamine absorbs maximally between 230 and 240 nm, and shows 
maxima in the region of 360 nm. Scanning spectroscopy indicated 4 peaks: 233 run (maximum); 351, 362 and 
374 nm. In the presence of saturating concentrations of CF3COOH new maxima at 240 nm and 325 nm were 
established. 
Table 3.2 gives the absorbance maxima for DPN at 230 nm and between 280 and 300 nm. In the presence of 
CF3COOH an immediate reaction occurred, visible by the colour change from yellow to blue. A peak in 
absorbance at 260 nm and a maximum absorbance in the visible region were established. Due to the 
hydrophobic character of DPN further experiments were carried out using DMN. 
In table 3.3 the conditions for DMN decomposition were investigat~d. At pH 7.6 no decomposition resulted 
after 30 mins of U.V. exposure, however in an acidic environment (pH 1-3) decomposition occurred after 
5 mins. No decomposition of the sample occurs when irradiated in pyrex glassware instead of quartz. 
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TABLE 3.1 ABSORBANCE OF DIMETHYLNITROSAMINE IN HEPTANE IN THE 
ABSENCE AND PRESENCE OF TRIFLUOROACETIC ACID 
Wavelength (nm) DMN (454~) DMN + CF3COOH (0.43 M) 
230 0.820 0.040 
240 0.928 0.600 
250 0.564 0.280 
260 0.200 0.080 
280 0.004 0.002 
300 0.004 0.004 
320 0.020 0.119 
340 0.072 0.072 
360 0.132 0.020 
380 0.082 0.016 
TABLE 3.2 ABSORBANCE OF DIPHENYLNITROSAMINE IN HEPTANE IN THE 
ABSENCE AND PRESENCE OF TRIFLUOROACETIC ACID 
Wavelength (nm) DPN(lOO~) DPN(lOOpM) + CF3COOH(0.43 M) 
230 1.239 1.354 
250 0.802 0.950 
260 0.503 0.971 
280 0.554 0.803 
300 0.582 0.786 
320 0.377 0.710 
340 0.150 0.718 
360 0.045 0.869 
380 0.022 1.068 
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TABLE 33 ABSORBANCE OF DIMETHYLNITROSAMINE8 IN AQUEOUS BUFFERED 
pH AND ACIDIC pH UNDER IRRADIATING/NON-IRRADIATING CONDITIONS 
pH7.6 pH 1-3 
Wavelength (run) Control Experimentalb Control 
220 2.936 2.945 2.966 
230 3.066 3.067 3.080 
240 3.103 3.105 3.U3 
250 3.060 3.060 3.083 
260 2.524 2.437 2.504 
280 0.086 0.092 0.138 
300 0.111 0.115 0.165 
330 0.420 0395 0.449 
365 0.056 0.061 0.063 
anMN at 136 mMJI 
bJrradiation of sample for 5 mins (Hg Lamp). 
Experimental 
1.976 
0.937 
0.431 
0.213 
0.119 
0.070 
0.073 
0.064 
0.049 
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3.3.2 Receptor- Ligand interactions 
Table 3.4 shows the interaction of DMN and the nicotinic cholinergic receptor. Receptor fractions from the 
chromatofocusing column (pH = 5.16) in the presence of DMN experienced a decrease in absorbance in the 
far U.V. region. Dialysis served to remove DMN as seen in "c". In "d", changes in the properties of the 
receptor were observed upon irradiation. Control experiments where receptor has been irradiated for 5 mins 
show the effect of the ultra-violet light to be minimal for this time period. Longer periods (10 mins) irreversibly 
denature the protein. A maximum absorbance between 280 - 300 nm appears to indicate a structural change. 
Removal of DMN by dialysis (11e 11) does not alter this structural change significantly, but allows for an increase 
in absorbance in the far U.V. region, as observed in control 11c". 
The interactions of DMN with semi-purified receptor from acetone powder were found to be similar to those 
above. A reversible interaction between DMN and the solubiliser, Triton X-100 became apparent, firstly 
because quenching of the absorbance at 238 nm was no longer present when using the detergent Tween - 20, 
and secondly because quenching of the receptors absorbance in the far U.V. region was not concentration 
dependent. 
Using gel chromatography (Sephacryl S-200), receptor protein elutes in the void volume whilst DMN elutes at 
VT. Elution of this sample after 5 mins irradiation shows; firstly, a marked increase in absorbance of the void 
volume fraction at 280 nm and 235 nm and secondly, a reduced absorbance at 235 nm at VT (results not 
shown). 
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TABLE 3.4 ABSORBANCE OF nAChR IN THE ABSENCE AND PRESENCE OF DMN UNDER 
IRRADIATING/NON-IRRADIATING CONDITIONS BEFORE AND AITER DIALYSIS 
Wavelength (nm) 
230 
250 
260 
280 
300 
320 
340 
aR = nAChR. 
bDMN at 2.83 mM/l. 
1.521 0.101 
0.188 0.223 
0.166 0349 
0.159 0.183 
0.095 0.100 
0.041 0.061 
0.020 0.032 
cs hours dialysis against 0.025 M/1 Imidazole buffer, pH 7.4 (21). 
drrradiation of sample for 5 mins. 
e5 hours dialysis of irradiated sample. 
1.496 0.404 
0.194 0.252 
0.052 0.166 
0.054 3.380 
0.050 3.411 
0.027 1.981 
0.020 0.078 
1.288 
0.165 
0.090 
0.519 
2.782 
3.008 
0.842 
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Table 3.5 shows DMN quenching the intrinsic fluorescence of the receptor protein resulting in near non-
specific saturation, however after 5 hours of dialysis, this fluorescence is enhanced approximately 10-fold. 
Similar results have been obtained with the enzyme (AChE) by co-workers in our laboratory (unpublished 
results). The effects of DMN in the presence of a saturating concentration of d-TbC, show clearly that the 
enhancement in fluorescence previously found is now no longer present. The above fmdings were established 
at both pH 7.4 and pH 4.5, with no significant difference at these pH values. 
From table 3.6, it can be seen that d-TbC quenches the fluorescence of the receptor by approximately 30% 
while acetylcholine quenches 4%. DMN in the presence of d-TbC results in 50% quenching and in the 
presence of saturating concentrations of acetylcholine 55% quenching. 
Attempts to derivatise DMN, under the conditions employed, proved unsuccessful. TLC analysis showed the 
formation of acid derivatives of 3,5 dinitrobenzoylchloride with no change in the Rp of DMN. 
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TABLE 3.5 EFFECf OF CHOLINERGIC LIGANDS ON THE INTRINSIC 
FLUORESCENCE INTENSI'IY OF nAChR BEFORE AND AFTER DIALYSIS 
Ligand 
None 
DMN (17.5 mM) 
DMN (17.5 mM) 
+ 
d-TbC (50~M) 
Relative Fluorescence 
Intensity 
100 
28.42 ± 0.707a 
31.45 ± 0.778 
n . = number of experiments 
amean ± SD 
bs hours dialysis against 0.025 Mil Imidazole buffer, pH 7.4 (21). 
Relative Fluorescence 
Intensity After Dialysisb 
125.7 .± 7.25 
269.1 .± 11.03 
123.3 ± 9.27 
n 
2 
3 
3 
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TABLE 3.6 EFFECT OF V ARlO US CHOLINERGIC LIGANDS ON THE 
INTRINSIC FLUORESCENCE INTENSITY OF nAChR 
Ligand Relative 
Fluorescence Intensity 
None 100 
DMN (8.28 mM) 42 ± 0.515a 
d-TbC (50pM) 79.71 ± 1.690 
Ach (55PM) 96 ± 0.540 
bnMN + d-TbC 51.75 ± 0.353 
CJ)MN + Ach 45.04 ± 1.06 
n represents the number of experiments 
amean ± SD 
hpretreatment of sample with d-Tu_bocurarine (501IM) 
Ctreatment of sample with saturating Ach. 
n 
3 
2 
2 
3 
2 
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3.4 Discussion 
The ultraviolet spectrum of dimethylnitrosamine shows two distinct bands in non-polar solvents. A strong band 
identified as a w: - w: transition (230-240 n.m) and a weaker band due to a n -w: transition {360 nm) {73). An 
increase in the polarity of the solvent results in a less pronounced structure as observed by the shift of the 
wavelength maximum (n - w:transition) to shorter wavelengths (325 nm). The formation of a new species is 
indicated by this spectral change and is therefore a function of the acidity of the solvent as shown by the 
interaction of DMN with CF3COOH. This interaction allows the formation of a hydrogen-bonded complex 
containing one equivalent of nitrosamine and one of CF3COOH (figure 1.4(IV)) (71). 
Based on the similarities in structure of DMN and DPN one can assume similar reactions. This is indeed the 
case when DPN and CF3COOH react. The observed colour change indicates extensive conjugation of the 
DPN-CF3COOH complex, forming structure (VI) in figure 1.4 with a characteristic quaternary nitrogen. The 
importance of this is that (IV) as for D'MN is photolabile whereas (VI) is not (71). 
In conclusion both nitrosamines are involved in hydrogen-bonded reactions in a slightly acidic environment. 
The reactivity of DPN however does not lend itself to photodecomposition due to the presence of the 
quaternary nitrogen. 
The U.V. spectrum of DMN in water (Table 3.3) is almost identical to the spectrum in non-polar solvents. 
Spectral evidence clearly shows the sensitivity of nitrosamines to different solvents, as demonstrated by the 
stability of DMN towards ultraviolet irradiation in neutral aqueous solutions (table 3.3) (50,71). The reason for 
the stability is that DMN is undoubtedly, extensively solvated by hydrogen bonding in the presence of water 
(72) and secondly, water is a poor hydrogen-atom-donating-solvent (71). An increase in the acidity of the 
aqueous solvent allows a hydrogen-bonding reaction to take place between the proton of the acid and DMN, 
since the hydrogen bond is probably stronger than that with any one water molecule. This hydrogen-bonded-
DMN com.plex is however less photosensitive than when in a non-polar solvent (50), hence requiring ultraviolet 
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irradiation for photodecomposition. The spectrum after irradiation and the fact that decomposition of DMN 
does not result when irradiated in pyrex glassware allows one to conclude that the N-N bond has been broken 
with subsequent radical formation (figure 1.4 (IV)). 
The interaction of DMN with purified and semi-purified receptor material under non-irradiating conditions 
clearly shows DMN interacts non-specifically with the receptor and with low affmity. The fact that energy-
transfer labelling does not occur under these conditions is not suprising, since decomposition of DMN does not 
readily occur in an aqueous environment. It was hoped that the active site region of the receptor, which is 
hydrophobic in nature, would mimic the medium in which nitrosamines are most photosensitive (50), however 
this does not appear to be the case. Ultra-violet irradiation of the DMN-receptor complex i.e. photoaffinity 
labelling, induces a structural change of the receptor protein. This conformational change is irreversible 
suggesting an inactivated complex. 
For photoaffmity labelling to occur, DMN must possess the characteristic quaternary nitrogen but 
simultaneously retain its photolability (figure 1.4 (IV)). It is for this reason that high concentrations of 
nitrosamine are required. 
Several factors may explain the irreversible conformational change, i.e. a change of the active site from a 
hydrophobic to a hydrophilic environment. Firstly it may be envisaged as a function of the photolabelling 
process. Secondly receptors, in the presence of high concentrations of agonists, are known to undergo 
conformational changes ( desensitisation) (3). This could therefore be the case for the receptor in the presence 
of DMN, even though desensitisation is known to be a reversible process (3). Thirdly, phosphorylation of the 
receptor in the presence of DMN (97). Finally denaturation of the receptor in the presence of U.V. light. 
Control experiments where receptor protein is irradiated in the absence of DMN exclude this possibility. 
The finding that DMN interacts with the solubiliser, Triton X-100, conclusively shows its non-specificity. 
The above shows evidence of a protonated residue in the vicinity of the active site of the receptor. This is 
based on the displaced ultra-violet spectra of the nitrosamines in the presence of CF3COOH, which is in 
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agreement with the literature (50, 69). It appears reasonable to suggest the presence of a tryptophan residue, 
(residing in a hydrophobic pocket of the receptor) which becomes exposed, in the presence of a nitrosamine, to 
a hydrophilic environment, and in doing so increases the residues accessibility. 
Fluorimetric observations of the interactions of DMN and the receptor support all of the spectrophotometric 
findings. The intrinsic fluorescence of the receptor is non-specifically quenched by DMN, emission observed at 
340 nm rather than 336 nm (6) or 345 nm (90). The difference in emission wavelength appears to depend on 
the solvent system and/or state of the purified receptor (active(mactive). 
Results show that energy-transfer labelling occurs in the presence of DMN with excitation wavelength at 290 
nm. This is in agreement with previous findings, showing energy-transfer labelling to be more facile than 
photoaffinity labelling (50). The fact that the hydrogen-bonding ability and not acidity of the solvent is 
important, is supported by the fluorimetric observations. Labelling occurred at physiological pH and in dilute 
acid conclusively showing that the receptor has specific physiochemical characteristics, prerequisite for efficient 
energy-transfer labelling. 
d-Tubocurarine, a competitive antagonist of the receptor blocks any specific interaction of DMN with the 
receptor. This supports the idea that the nitrosamines are potential nicotinic receptor agonists, causing 
conformational changes of the receptor. This conformational change is the formation of a desensitised 
(inactive) receptor, with a higher affmity for agonists (1). No mention has as yet been made as to the 
spectroscopic properties of a desensitised nicotinic receptor. It has been shown that known agonists such as 
acetylcholine cause slight quenching of the receptors intrinsic fluorescence, in agreement with the literature 
(110). d-Tubocurarine similarly causes quenching, more marked however than other known agonists, 
suggesting some non-specific interactions (102). The fact that the a -cobratoxins also cause marked quenching 
( 4D) supports the findings with d-TbC. 
Competition at the active site of the receptor is clearly evident when both acetylcholine and DMN are present, 
supporting the postulation that the nitrosamines are potential agonists. The non-specific interactions of the 
nitrosamines would appear to be due to the oxygen atom of the molecule. Any derivitisation of this atom would 
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produce structure (VI) in figure 1.4. The presence of the quaternary nitrogen would increase the affinity and 
specificity of the ligand for the receptor with, however a simultaneous loss of photo lability. 
In the presence of DMN it can be seen that the reversible (desensitised) and irreversible conformational 
changes of the receptor improve its detection. The non-specificity of DMN however precludes its use for 
purifying the receptor. 
CHAPTER 4 
ISOLATED ORGAN STUDIES OF XENOPUS LAEVIS RECTUS 
ABDOMINIS MUSCLE 
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4.1 INTRODUCTION 
The simplest method used to study cellular responses triggered by nicotinic cholinergic receptors is the 
recording of a mechanical response, namely muscle contraction (4). A widely employed preparation is the frog 
rectus abdominis muscle, consisting of nicotinic receptors, i.e. the receptors recognise the agonist, nicotine and 
the antagonist, d-Tubocurarine (37). This method allows for the determination of agonistic properties of 
ligands and simultaneously improves our understanding of the structural- functional aspects of this receptor. 
Ligands of the nicotinic system, invariably are characterised by a quaternary nitrogen atom at physiological pH 
and are usually hydrophilic (37). The investigation of pH-dependent charged ligands such as 
dimethylnitrosamine (DMN) and diphenylnitrosamine (DPN) - which is lipophilic- allows inferences 
concerning the structural requirements and accessibility of cholinergic ligands. 
Interactions in the absence and presence of light (photoaffmity or energy-transfer labelling) on the nAChR 
preparation have been undertaken. Competitive displacement studies and dose-response curves are presented. 
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4.2 MATERIALS AND METHODS 
4.2.1 Materials 
Ringers solution prepared as follows: 
&1 
NaCI 6.5 
glucose 2.0 
KCl 0.14 
CaCl2 0.12 
NaH2P042H20 0.034 
NaHC03 0.2 
Reagents: 
Phenyltrimethyl ammonium iodide was obtained from Hopkins and Williams Ltd. England. 
Polyethyleneglycol (PEG) 400 obtained from May and Baker Ltd. Dagenham, England. 
Diphenylnitrosam.ine solutions prepared in PEG 400: ethanol (3:7). 
2, 3, 5-Triphenyl-tetrazolium chloride was obtained from BDH Ltd. England. 
p-Nitroso-N,N-dimethylaniline. Prepared by associates in our laboratories (mpt. 55-60oC). 
All other reagent solutions were prepared as in chapter 2 and 3. 
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4.2.2 Methods 
4.2.2.1 Dissection and attachment of muscle 
Female Xenopus laevis were swiftly stunned and pithed. Dissection and removal of the muscle was carried out 
immediately and placed in Ringers solution at physiological pH. The muscle was then attached to a transducer 
and suspended in a 50 cm3 organ chamber (see figure 4.1), with constant aeration- 95% 02 and 5% COz at 
20°C (119) and allowed to equilibrate (30 mins). 
4.2.2.2 Experiments performed under non-irradiating conditions 
After equilibration of the muscle, small doses (10-500lll) of the ligand/s of interest were added directly to the 
chamber and the response monitored graphically. Calculation of the volume of ligand to be added to the 
chamber, for the cumulative dose-response curves, can be seen in appendix 5. 
At the end of an experiment the chamber was drained, washed twice and then allowed to re-equilibrate until 
base-line levels were obtained. 
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4.2.2.3 Photolysis experiments 
Photolysis of the chamber contents was carried out using the Hanovia (Hg) lamp placed 5 ems from the quartz 
chamber. A maximum of 5 mins exposure was allowed due to the damaging effects of U.V. light on muscle 
preparations. pH changes of the Ringers solution were brought about by adding small amounts of HCl (50-200lll). 
Figure 4.1 Equipment used for isolated organ chamber studies 
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4.3 RESULTS 
4.3.1 Experiments performed under non-irradiating conditions 
In figure 4.2 the response of equimolar concentrations of the agonists, acetylcholine (a) and phenyltrimethyl 
ammonium (PTMA) (b) can be seen. PTMA exhibits a longer open channel time and is a more efficient 
agonist with a 3.3 times greater response. 
The cumulative dose-response curve for DMN (figure 4.3) gives an EDso value (i.e. concentration of ligand 
giving half maximal response) of 56 mM. This is considerably higher than that for acetylcholine (398 llM) 
(results not shown). 
In the presence of the competitive antagonist, d-TbC, the EDso value for DMN increases to 100 mM at 2l!M 
d-TbC and 177 mM at 6l!M d-TbC. This increase is indicative of competition at the active site of the receptor. 
Complete blockage and reversal of the DMN response with d-TbC is seen in figures 4.4 and 4.5 respectively. A 
6 liM concentration of d-TbC is sufficient to block the DMN response whereas a 200 llM concentration is 
required to cause complete reversal. 
It can also be seen (figure 4.5) that the response elicited by DMN is much slower than that of acetylcholine. 
Control experiments consisting of ethanol and PEG 400 were carried out for the cumulative dose response 
curves for DPN, (figure 4.6) but were found to have a negligible effect on the muscle. From figure 4.6 the 
EDso value for DPN was found to be 790 l!M. In the presence of d-TbC this value increased as follows: at 
lOJJM d-TbC, EDso is 1 mM DPN; at 50l!M d-TbC, EDso is 1.58 mM DPN and at 100llM d-TbC, EDso is 2.5 
mM DPN. Again this increase is indicative of competition at a common interacting site. 
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Figure 4.2 Response of rectus abdominis muscle (a) on addition of 
acetylcholine (3 x 10-S Mil) and (b) addition of 
phenyltrimethyl ammonium ioclide (3 x 10-S M/1) 
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Figure 4.3 Cumulative dose-response curves showing the effect of 
DMN (It), DMN plus d-TbC (2 x 10 -6 M/1) (t-) and DMN plus d-ThC 
(6 x 10-6 M/1) {)9 on the rectus abdominis muscle. 
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Figure 4.4 Response of rectus abdominis muscle (a) on addition 
of DMN (1.3 x to·2 M/1) and (b) pretreated with 
d-Thc (6 x to-6 M/1). 
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Figure 4.5 Response of rectus abdominis muscle {a) on addition 
ofDMN (1.3 x 10-2 M/1) and (b) treated with d-ThC 
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Interactions of acetylcholine and DMN on the muscle were investigated. From figure 4.7 it can be seen that a 
10 mM DMN dose does not elicit any response (b), however in the presence of acetylcholine (a) a gradual 
response occurs. In (b) the acetylcholine response is potentiated by a factor of 2. 
Figure 4.8 shows the interactions of DPN and acetylcholine with the muscle to be similar to those of DMN and 
acetylcholine (figure 4.7). However, at 1 mM DPN a response is elicited resulting in only a slight potentiation 
(b) due to competition at the active site. 
Compounds such as 2-3-5 Triphenyl-tetrazolium chloride and p-Nitroso- N,N-dimethylaniline were also tested 
for nicotinic receptor activity. These however did not cause any muscle contraction. 
All of the above interactions were further investigated at a pH of 5.6. It was shown that both the known 
agonists and the nitrosamines produced an increased response(2-fold) at this pH. 
4.3.2 · Photolysis experiments 
Ultra-violet irradiation of the DMN-receptor complex (5 mins, pH 5.6) (figure 4.9), allows only 66% of the 
original acetylcholine response. This indicates inactivation of a number of active sites previously available to 
acetylcholine. 
Control experiments in the absence of ligands show firstly, that ultra-violet exposure does not result in any 
inactivation of the muscle preparation and secondly, only a slight increase in bath temperature (20C) occurs 
over a period of 5 minutes. Under similar conditions in the presence of DPN no change in the acetylcholine 
response was observed. 
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Figure 4.7 Response of rectus abdominis muscle (a) 
on addition of acetylcholine (10-4 Mil) plus 
DMN (lo-2 Mil), and (b) pretreated with 
DMN (lo-2 M/1). 
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Figure 4.8 Response of rectus abdominis muscle (a) on 
addition of acetylcholine (10-4 Mil) plus 
DPN (lo-3 M/1), and (b) pretreated with 
DPN (10-3 M/1). 
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4.4 DISCUSSION 
Known agonists of the nAChR; acetylcholine (figure 1.5 (iii)) and phenyltrimethyl ammonium (figure 1.5 (iv)) 
activate the receptor-cation channel causing muscle contraction (3). The observed difference in efficiency (i.e. 
intrinsic activity) of these agonists is due to the partial negative charge on the electron-attracting benzene ring 
of PTMA substituting for the carbonyl oxygen of acetylcholine (77). 
The ability of DMN to act as an agonist of the receptor is confirmed in figure 4.3. This result shows the 
following : Firstly, DMN is a "full agonist" (i.e. capable of producing a maximal response at a sufficiently high 
concentration), secondly, it is a very weak agonist and has a low affinity for the receptor reflected in its high 
ED5o value. Thirdly, its interaction with the receptor is reversible and therefore "ionic" in nature. Finally, 
competition with antagonists such as d-TbC, allow one to conclude a common interacting site. 
The fact that it is a weak agonist and of low affinity can be attributed to the lack of a permanent quaternary 
nitrogen, suggesting non-specificity. 
The finding in our laboratory that DMN causes contraction of intestinal smooth muscle (i.e. interacts with 
muscarinic receptors) confirms the non-specific nature of its interaction. The distance between the quaternary 
nitrogen and the oxygen atom (figure 1.5 (ii)) suggests the possibility of two DMN molecules interacting 
simultaneously with one acetylcholine binding site. 
Since ionic interactions are the major forces involved in ligand-receptor recognition, it is not surprising that 
these same forces are involved in DMN recognition. 
The competition between DMN and d-TbC for the active site (figures 4.3, 4.4 and 4.5) shows firstly, that DMN 
is a true agonist; secondly, the presence of DMN results in desensitisation of the receptor and thirdly, d-TbC 
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binds preferentially to a receptor in a resting state (non-desensitised) and does not result in any detectable 
activation of the receptor (104). 
The accessibility of DMN to the active site of the receptor is controlled by factors such as solvent polarity, pH 
and the state of the ligand (i.e. charged or uncharged). Since a 1:1 ratio of charged to uncharged species occur 
(figure 1.4 (I) and (II)), it can be assumed that DMN reaches the active site of the receptor via an aqueous 
and/or hydrophobic path. 
The delayed response of the muscle in the presence of DMN can be observed in figure 4.5. This is due to the 
fact that DMN is a weak agonist and interacts poorly with the receptor. Also, the interaction requires the 
displacement of water (82) and/or Ca2 + ions (6) to allow for destabilisation of the closed channel state. 
From chapter 3, it was assumed that the high reactivity of DPN with CF3COOH would enhance its affinity for 
the receptor (-N+) but simultaneously due to steric influences reduce its intrinsic activity (37) . The results 
clearly show DPN to be as efficient an agonist as DMN. DPN however displays a higher 
affinity for the receptor evident by the lower EDso value. Since the EDso value for DPN is higher than that for 
acetylcholine, one can assume that the bulky phenyl groups interfere sterically and that the distance between the 
quaternary nitrogen atom and the oxygen is not optimal (as for DMN). 
DPN, is therefore a "full agonist", interacts through ionic forces and competes with d-TbC for the active site. A 
combination of steric and inductive effects account for its higher reactivity. 
The interactions of DPN and d-TbC with the receptor reflect the increased potency of DPN. Whereas low 
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concentrations of d-TbC are capable of blocking a response by DMN much higher concentrations are required 
to prevent a response by DPN. 
A delayed response by DPN (not shown) appears to indicate that it reaches the active site via a hydrophobic 
path. Since the rate of muscle contraction by both DMN and DPN are similar, it would appear that DPN also 
has access through an aqueous path, suggesting the presence of a high percentage of charged DPN molecules 
(in agreement with results). 
Pretreatment of the rectus muscle with acetylcholine (figure 4.7 (a)), and subsequent addition of DMN, (at a 
concentration not effective in eliciting a contraction) indicates firstly, that a conformational change of the 
receptor is important for receptor activation and secondly, that DMN at this concentration interacts with only 
one binding site. 
In (b), potentiation of the previous acetylcholine response in (a), reinforces the fact that a conformational 
change is important for activation. 
Positive cooperativity has been suggested i.e., a molecule binding to one site of the receptor induces structural 
changes enhancing the binding of a second molecule (6). The second ligand binding site can be thought of as a 
poor complement to the ligand, forming incomplete contacts with the receptor when it is in a resting state (82). 
From the results it can be seen that DMN binds with very low afftnity to the receptor and because of this is 
capable of only interacting with the more accessible binding site. This interaction results in a conformational 
change, which is necessary for receptor activation. Higher concentrations of DMN are however required to 
interact with the second ligand binding site. This second site controls the receptor-cation channel and thus the 
response. It is well documented (6, 15, 80-82), that receptor activation is greatest when both agonist binding 
sites are occupied. The results support this and the notion that the two binding sites are of equal affinity when 
the channel is open (3, 80, 82, 83). 
In conclusion then, it can be seen that the potentiated response m figure 4.7 (b) lS firstly due to a 
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conformational change of the receptor in the presence of DMN, and secondly allows acetylcholine to interact 
with the second ligand binding site, activating the cation-channel. 
The interactions of DPN in the presence of acetylcholine (figure 4.8) (a) and (b), can be explained in much the 
same way as for those of DMN. The response (i.e. muscle contraction) by DPN (b) however results in 
competition at the active site evident by the less marked potentiation normally associated with the presence of 
two agonists. 
It is suggested that desensitisation of the receptor can either occur in a fast-step in the millisecond time region 
or a slow-step in the second time region (89). 
The different states of the receptor (i.e. resting, active and desensitised) are proposed to be interconvertible 
allosteric transitions (1). One can therefore view the transition from low affinity to high affinity state as being 
the same molecular transition as desensitisation (91). 
The fact that two agonist molecules are necessary for receptor activation whereas only one molecule IS 
sufficient for desensitisation (3) is clearly supported by the results. 
The non-specificity of DMN and DPN would suggest that these ligands are not only agonists but are also 
capable of interacting with the membrane and/or ion-channel complex. Since non-competitive inhibitors are a 
very heterogeneous group (105) interacting with the ion-channel, DMN and DPN could possibly be viewed as 
N.C.I., however, from the results this does not appear to be the case. 
The presence of a quaternary nitrogen does not imply that a ligand must bear agonistic properties. Specific 
geometrical requirements are necessary for nicotinic recognition and activation. 
A drop in the pH of the medium, from a physiological pH to a pH of 5.6 results in marked changes. The effect 
1, 0 
of an increase in hydrogen ions on the receptor-channel complex appears controversial. The finding that an 
increased response occurred at a lower pH is in contradiction with other findings, which suggest that hydrogen 
ions block the ion-channel (3). 
More importantly however, photolysis of the muscle preparation at pH 5.6, in the presence of DMN results in 
an irreversible modification of receptor response (figure 4.9). Only 66% of an original acetylcholine response 
is permitted which suggests that an irreversible desensitised conformation is established through covalent 
insertion (alkylation), or that increased desensitisation of receptors occurs due to the continued presence of 
DMN (83). Control experiments suggest the former to be correct. Since DMN at this concentration (figure 
4.7) does not exhibit any biological activity, photoaffmity labelling of the receptor indicates that similar 
mechanisms control both activation and desensitisation. This is in agreement with the literature which states 
that a disulphide bond, which is intimately involved in the local conformational changes at the active site leads 
to activation (94) and desensitisation (95). 
The irreversibly modified response, in our findings, can be compared to that of other findings (69), where only 
24% decomposition of a derivatised nitrosamine occurred in the presence of the enzyme, acetylcholinesterase. 
The fact that photolabelling of the receptor by DPN does not occur can be extended to its lack of photolability 
in the presence of the receptor. 
CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
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Despite the nicotinic cholinergic receptor being the most well-characteristed neurotransmitter receptor, there 
are still some basic problems which remain unsolved. Firstly, a crucial one is the difference between agonists 
(which bind and trigger an effect) and competitive antagonists (which bind with comparable afflnity but do not 
gate the ion-channel). From the mere chemical structure of the effector molecules this difference is not 
obvious (3). Secondly, little is known about the identity of the ion-channel and its gating mechanism(s). 
Due to certain characteristic features of the nitrosamines such as pH dependency, a bydropbobic/bydropbilic 
balance and a photolabile functional group allows one to gain considerable insight into the receptor-channel 
complex. With this in mind the present study was designed to provide a means for isolating and purifying the 
receptor with specific label at the active site. 
The question remains whether the "fish receptor", from Torpedo fuscomaculata, is a model for the nAChR from 
other species and higher vertebrates. The answer is "yes". This is not surprising since electroplaque cells 
pbylogenetically evolved from striated muscle cells (3). In an adult electromotor or neuromuscular junction, 
the distribution of the acetylcholine receptor is largely restricted to the cytoplasmic membrane which underlies 
the nerve ending. In this region, the receptor density reaches a value of about 15 000 to 20 000 molecules /llm2 
{2). This high density facilitates the purification of the receptor. 
The lipid environment of the receptor exerts a critical, although permissive action on the regulatory properties 
of the receptor. Whereas solubilisation, which releases the receptor from its membrane components, is 
suggested to alter regulatory properties, receptor molecules have been shown to retain their integrity and ability 
to recognise agonists and antagonists. This suggests conformational changes of the receptor to be reversible. 
Due to serious problems created by proteolysis, maximum precautions should have been taken i.e., a "cocktail" 
of protease inhibitors in all of the solutions used. Despite extensive degradation in receptor preparations 
ligand-receptor recognition still occurred suggesting that the functional integrity of the receptor remained 
intact. 
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Problems in accurately determining specific radioactivities of labelled preparations (2) were circumvented by 
employing the specific antagonistic properties of d-Tubocurarine. An accurate assessment of purity was 
achieved even though some non-specific interactions in crude-receptor preparations occurred. Finally, the 
values of specific activity are based on protein determinations made with soluble standard, serum albumen, 
which may not behave appropriately in the modified Folin-lowry reaction (2). The protein content of the 
crude-receptor fractions were found to be low in comparison to other reported fmdings, resulting in lower 
specific activities. 
Recovery of active receptor through use of an easily identifiable physical parameter allowed for an improved 
purification by chromatofocusing over that of affinity chromatography. Even though the ex-neurotoxins exhibit 
an extremely high affinity and specificity for the receptor, the majority of receptor is lost in an affinity 
chromatographic system. 
It has been shown that ion-exchange resins, such as commercial Sepharose, are an improvement on Sephadex 
resins, allowing for higher recoveries in smaller volumes. They are however,not sufficiently characteristic 
allowing for recovery of receptor associated with tightly bound non-specific proteins. 
The nAChR has been shown to consist of four different subunits constituting a receptor monomer of 
approximately 230 kDa.These monomers are linked through 5- 5subunits to form a dimeric molecule which is 
integrated in the post-synaptic membrane. 
A physiological response i.e., contraction of rectus abdominis muscle, has shown nitrosamine compounds to be 
true agonists of the nAChR. The fact that they interact weakly with the receptor and are non-specific, due to a 
transient quaternary nitrogen, precludes them as photoaffmity ligands of the nAChR. 
Structural-functional studies of receptor-ligand interactions indicate specific geometrical requirements for 
receptor activation. Since the distance between the quaternary nitrogen atom and negative group of the 
nitrosamines is not optimal for nicotinic receptor activation, weak interactions occur. For the case of DPN 
however, the possibility exists that the distance between the nitrogen atom and electron-dense benzene ring is 
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more optimal allowing for a stronger interaction with the receptor. 
It has been shown that desensitisation of the receptor occurs in the presence of high concentrations of agonist 
and involves the same molecular transition as receptor activation. The fact that the response (i.e. muscle 
contraction) is delayed in the presence of the nitrosamines can be attributed to the accessibility of these ligands 
to the active site. 
In conclusion, it remains an open question as to whether all of these effects of neurotransmitters and ligands on 
voltage-sensitive ion-conductances observed in vitro should necessarily be considered simulations of normally 
functioning synaptic interactions observed in vivo (120). Neurotransmitters and their receptors are therefore 
likely to remain a productive focus of future research. 
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APPENDIX! 
Gel Chromatogram of Standard Molecular Weight Compounds on Sephacryl S-400. 
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APPENDIX2 
Standard Curve for the Determination of Molecular Weight on gel chromatography 
8 
7 
6 
5 
4 
3 
2 
1 
10 20 30 40 50 60 70 80 90 100 
ELUTION VOLUME (em 3 ) 
a - blue Dextran 
b - lactate Dehydrogenase 
c - DNase 
d - carboxypeptidase A 
129 
APPENDIX3 
Standard Curve for the Determination of Molecular Weight by SDS-PAGE 
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APPENDIX4 
Standard Curve for the Determination of Protein by the modified Lowry Method (116). 
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APPENDIXS 
Calculation of volume of ligand to be added to the isolated organ chamber for the cumulative dose-response 
curves. 
50JJ{ of a stock solution of ligand (lo-5 Mil) gives a final concentration of 10-8 M/1 in the chamber. 
To achieve a lo-7 M/1 final concentration, 451.l of stock solution (10-4 Mil) must be added. 
*Calculated as follows : 
(1 X 10-7) - (1 X 10-8) 
= 9 x 1o-8 
hence multiply : 9 x 50pl 
= 450li 
hence divide : 450+ 10 
= 45Ji 
